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A me stessa… 
“chi fa da se, fa per tre” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
L’UOMO DI SCIENZA 
 
La scienza è rigore imprescindibile. 
La razionalità sovraintende guardinga, 
la conoscenza accresce nel tempo, 
la saggezza è la meta lontana. 
 
Non ci sono vie di fuga, 
i confini sono marcati. 
 
La scienza è inevitabilmente scienza. 
 
L’uomo è fantasia inaudita. 
La debolezza  schierata lo attende, 
la paura paralizza l’azione, 
la felicità sprigiona energia. 
 
Non esiste logica nella vita, 
la passione elude ogni limite. 
 
L’uomo è inevitabilmente uomo. 
 
E poi c’è… l’uomo di scienza.  
 
V.P. 
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1. LITERATURE REVIEW 
 
In Europe, the 1990s was the decade in which the “mad cow disease” (BSE) scandal hit 
the European food sector, the implementation of the Single European Market began, 
and thus a time where new issues about the integration and harmonisation of procedures 
in food production, processing and regulation emerged. The BSE case resulted in a 
collapse of public confidence in the organisations handling food safety. The crisis 
helped put food safety at the top of the political agenda in Europe. As a result food 
regulation underwent serious reorganisation in EU (Binnis, 2009; Holm and Halkier, 
2009).  
European food safety regulation before the 1990s has been described as fragmented, 
reflecting a food market made up of national markets in which national governments 
have used food safety regulation as a competitive tool for domestic markets (Berhauer 
and Carduff, 2006). National regulations mirror different national food cultures and the 
aspects of food they prioritise and focus on. In response to the BSE scandal the EU 
Commission prepared a White Paper on Food Safety which stated: “The European 
Union needs to re-establish public confidence in its food supply, its food science, its 
food law and its food controls” (EU Commission, 2000). The changes on the agenda 
were not only within the food producing sector, but also in the legal and regulatory 
framework, in the division of responsibility between social actors, in the public 
authorities in charge of food control, and in the conduct of the science lying behind the 
regulation of food safety (Giorgi and Lindner, 2009; Holm and Halkier, 2009). 
Knowledge derived through scientific research has resulted in the development and use 
of new technologies that have had a profound impact on food animal agriculture. These 
advances have increased the efficiency of food production and providing significant 
quantities of high-quality food. The bottom line is how enhance food production as well 
as animal health and ensure public health and sustainable agriculture (Oliver et al., 
2009).  
More than 200 known disease are transmitted through food by a variety of agents, 
including fungi, viruses, parasites, and bacteria. Foodborne illness is a major factor 
contributing to morbility and mortality in worldwide. Many zoonotic and nonzoonotic 
source of microbial pathogens could breach the food safety barrier. Food safety begins 
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with soil, plant, or animal, and continues within the plant or animal through various 
stages of production and processing (Oliver et al., 2009).  
There has been a surge of research activity into pathogens reduction strategies that were 
mainly inspired by the HACCP initiative. All food-processing plants were required to 
have an HACCP system in place that include the ability to trace foodborne pathogens 
back to the production unit. The food production unit needs a system to detect the origin 
of the contamination as well as effective measures to reduce microbial contamination 
(Oliver et al., 2009). 
Food can become contaminated by a variety of factors: zoonotic or nonzoonotic, direct 
or indirect. Farm-associated pathogenic bacteria are directly or indirectly associated as 
risk factors in the entire commercial food chain. Animal activity on the farm, manure 
management, and effluent discharge influence bacterial populations in farm soil as well 
as associated pathogenic flora. New technologies to reduce bacterial contamination 
based on prebiotics or probiotics for competitive exclusion seem promising. New tools 
for pathogen detection and pathogen modelling hold considerable promise for 
influencing research and measurable out comes in food safety (Wiedmann, 2003). 
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1.1. FOOD SAFETY LEGISLATION 
 
The EU Commission’s White Paper on Food Safety (2000) states that the essential role 
of the Internal Market “is to offer to consumers a wide range of safe and high quality 
products coming from all Member States” (EU Commission, 2000). As the food 
production chain is becoming increasingly complex, the health of consumers can only 
be adequately protected if every link in this chain is “as strong as the others”. Restoring 
public confidence thus involved all parts of the food sector. That is, a farm to table 
policy was required. Five key principles guided the Commission’s suggestions: clear 
definitions of the roles and responsibilities of stakeholders in the food chain; traceability 
of feed and food and their ingredients; transparency of food policy; risk analysis as the 
foundation on which food safety policy is based; and the application of the 
precautionary principle in risk management decisions. Last but not least, the need to 
involve individual consumers actively in food safety policy, and in the handling of food 
safety, was underlined (Holm and Halkier, 2009). An attempt was made, then, to 
encourage and direct societal actors to take part in the strategies for handling the 
problem of food safety. In this respect, the new EU food policy is an example of the 
alleged shift in political management, from the “dirigiste” approach towards a more 
regulatory approach (Majone, 1994). 
The EU system has been described as the “Regulatory State par excellence” (Knill and 
Lenschow, 2004). It adopts a mode of governance which builds on regulatory capacities 
already existing within regulated sectors, such as the in-house control systems in 
modern food industry, thus blurring borders between public and private authority. It 
changes top-down authoritative control by decentralising regulatory processes, allowing 
access to and spreading responsibility across economic and social actors such as food 
manufacturers, food retailers and consumers. This new form of governance allows 
governmental centres of command and control to be replaced by semi-autonomous 
agencies such as the new risk assessment agencies in Europe, which often operate 
outside the hierarchical control of the central administrations (Majone, 1994). In this 
manner power is thought to be delegated from politicians to experts. This offers a 
solution to the problem of lack of expertise among policy-makers (Holm and Halkier, 
2009). 
The new EU initiatives in relation to food safety policy were deeply inspired by the 
changes in the United Kingdom. 
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1.1.1. The New European Food Regulation 
The White Paper on Food Safety lays down the key principles for governing food law in 
the EU – these principles were translated into law through the General Food Law, 
Regulation EC 178/2002. 
In January 2002 the new European Food Regulation was adopted (Regulation (EC) 
178/2002). Thereby a framework was provided to ensure a coherent approach in the 
development of food legislation in order to ensure the free movement of food and feed 
in the EU. The regulation aims at ensuring a high level of protection of human life and 
health. It covers all stages of food/feed production and distribution and was to be 
implemented by all member states no later than 2007 (Marvin et al., 2009). The primary 
responsibility for ensuring the safety of food rests with the food business. The 
regulation establishes in EU law that risk assessment, risk management and risk 
communication provide the basis for food law. Transparency of legislation and effective 
public consultation are seen as essential elements of building greater consumer 
confidence. In all countries it is now official policy that principles for food safety 
inspection have changed. The adoption of HACCP principles which are suggested in the 
regulation implies that post-factum product control is substituted by process control. 
Part of the EU regulation was the establishment of new organisations and new 
institutional division of responsibilities. (Holm and Halkier, 2009). 
1.1.2. Institutional Reorganization 
The new risk policy was therefore to cover the whole food production chain from 
plough to plate and to separate responsibility for risk analysis from that of risk 
management. An independent authority - the European Food Safety Authority (EFSA) - 
was set up in 2002 with main responsibility for risk assessment of all categories of 
potential food hazard (Holm and Halkier, 2009; Kleter et al., 2009).  
The EFSA was established in 2002 as an autonomous agency following the decision in 
the framework of the European food safety law to separate the two tasks of risk 
management and scientific risk assessment. EFSA took over the task of carrying out and 
coordinating risk assessment and communication at European level. The scientific work 
of EFSA is carried out by 10 panels. Each of the panels may initiate a study on their 
own or upon request by one of the risk managers at Member State level or the European 
Commission. The European Commission will almost always ask the EFSA to carry out 
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a scientific assessment when confronted with a request for an authorization of a product 
or company (Giorgi and Lindner, 2009). 
Risk management was placed in the General Directorate for Health and Consumer 
Protection (DG Sanco) which became responsible for ensuring food safety through 
farm-to-table measures. A Standing committee on the Food Chain and Animal Health 
and a Rapid Alert System for Food and Feed (RASFF) were set up. Under the RASFF 
system, members, such as national food control authorities of the European Union (EU) 
member states, are obliged to notify any measures regarding to food safety, such as 
recalls of food and feed products and arrestment of imported consignments not 
complying with food legislations. The introduction of RASFF has further formalized as 
procedure of centralized reporting that existed before RASFF (Giorgi and Lindner, 
2009; Kleter et al., 2009).  
All countries reduced the number of organisations responsible for food safety and to 
clarify the division of responsibilities. In most countries new organisations were built 
with an overall responsibility for food safety for the whole food chain. A clear 
separation between consumer and producer interests was a priority. The new EU risk 
policy was therefore based on the separation of three steps: assessment, management 
and communication. This was attempted by placing risk assessment at the new 
independent European Food Safety Authority and by placing risk management and 
communication at the General Directorate for Health and Consumer Protection (DG 
Sanco) in collaboration with food control systems of member states. EFSA was set up 
independently from government in an attempt to restore confidence in scientific 
expertise, to re-establish neutrality of ‘science’ and thus to create an independence 
lacking to the “government scientist” (Wales et al., 2006). Integral to the new EU risk 
policy was the intention to separate responsibility for legislation from that of inspection. 
In the EU, legislation is the responsibility of the Council of Ministers, whereas 
responsibility for enforcement lies with DG Sanco (Holm and Halkier, 2009). 
The European Commission publishes weekly overviews of RASFF alert and 
information notification on its website. In addition, it publishes annual reports of the 
notifications. These annual reports provide an overview of the numbers of notifications 
and categories of food products and hazards that they pertained to. Some members of 
the RASFF network, including the Italian, German, and Swedish authorities, also 
publish updates and reviews of the data reported through RASFF, sometimes with a 
particular focus on their national situation. 
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Numerous projects were sponsored by the European Commission, such as SAFE 
FOOD. This is the acronym of an integrated project sponsored mainly by the European 
Commission as part of it’s the Sixth Framework Program for Research and Technology 
Development. This project aims to develop and ameliorate methods for risk assessment 
and risk analysis of food safety. SAFE FOOD consist of various work packages 
addressing specific topics within the field, including the use of advanced analytical 
methods for detecting changes in crops caused by agricultural practices; the use of 
advanced statistical methods to estimate cumulative human exposure to multiple food 
contaminants and natural toxicants; consumer perception of food safety management; 
institutional arrangements for implementing food safety policies; and the development 
of a new risk analysis model for food safety (Kleter et al., 2009). 
 
1.1.3. WTO framework: SPS and TBT agreements 
The EU scope is to provide the highest level of protection of human health and to 
facilitate both national and international food trade. At international level, a risk 
analysis approach is fundamental for the implementation of the World Trade 
Organisation (WTO) Sanitary and Phytosanitary Agreement (SPS Agreement) (WTO, 
1995). At European level, Regulation (EC) No.178/2002 (OJEU, 2002) sets the general 
principles and requirements of food safety law including the need of a risk analysis 
approach, and it also establishes the European Food Safety Authority (EFSA) (Binnis, 
2009; Hugas and Tsigarida, 2008). 
The international food policy regime as it relates to trade is defined by two WTO-
agreements: the Agreement on the application of sanitary and phytosanitary measures 
(hereinafter referred to as the SPS agreement) and the agreement on technical barriers to 
trade (hereinafter referred to as the TBT agreement) (Giorgi and Lindner, 2009). 
When adopting sanitary and phytosanitary (SPS) measures, each country is entitled to 
establish an own appropriate level of protection, under the condition that this is ‘applied 
only to the extent necessary to protect human, animal or plant life or health’, is based on 
scientific principles (SPS, Article 2.2), and does not discriminate between members 
(SPS, Article 2.3), that is, it is not used for protecting domestic markets from 
international importers. The obligation to base SPS measures on scientific principles 
obliges members to either base their measures on international standards (SPS, Article 
3), or on scientific risk assessment (Articles 5.1, 5.2, and 5.3). 
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If a member chooses to base its SPS measure on international standards, guidelines and 
recommendations, the SPS agreement recommends three standard-setting reference 
organizations, also called the ‘three sister organisations’: in the case of human health 
this is the Codex Alimentarius Commission (CAC); in the case of animal health it is the 
World Organization for Animal Health (OIE); and in the case of plant health it is the 
International Plant Protection Convention (IPPC). Adopting the standards of the WTO 
reference organizations is not obligatory (Giorgi and Lindner, 2009). 
TBT measures cover technical regulations, standard, and conformity assessment 
producers. The TBT agreement covers all technical regulations, standards and 
conformity assessment procedures except when these are sanitary or phytosanitary 
measures. 
Whereas the TBT agreement attends to labels established for reasons other than those 
intended to protect human, animal or plant health, the SPS Agreement attends to labels 
intended to protect human, animal or plant health (Giorgi and Lindner, 2009). 
 
1.1.4. Standardization agencies 
Standards institutes exist in most countries and are in charge of elaborating technical 
standards and guidelines in various sectors. Today most national standards institutes 
operate in a coordinated way within the international framework established by ISO and 
CEN. The European Committee for Standardization (CEN) develops technical standards 
(EN standards) for analytical methods used for establishing levels of contamination, or 
methods applied in sampling and analysis. 
At the international level, the International Standardization Organization (ISO) brings 
together standards institutes from 157 countries from either government or industry. It is 
set up as a non-governmental organization and claims to occupy “a special position 
between the public and private sectors”(Giorgi and Lindner, 2009). 
 
1.1.5. The new role of consumer 
The outcome of the BSE crisis was thus increased priority to consumer interests and 
protection of consumer health. Thus ‘the consumer’ became a central food policy actor 
(Marvin et al., 2009). Traceability and labelling was seen as a tool for consumer control 
over all steps of the food chain, that is, as a means of direct control by consumers on 
market actors. 
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Consumers were not to be protected from market excess but seen as an omnipresent and 
unpredictable figure that needed to be taken into account. Further, focus was now on the 
consumer as an individual market actor and not as a member of a political organisation 
(Halkier and Holm, 2008). Even though the interests and concerns of consumers are 
framed in different manners by various actors in the countries (Halkier et al., 2007) the 
shift towards a clear priority of consumer protection and consumer interests can be 
found in several countries. Securing the credibility of the food production chain is the 
first proposed objective of the new agency for Food Quality and Safety proposed in 
2000. In some countries this new prioritising of consumer interests also show in new 
policies regarding the workings of the administrative system, incorporating consumer 
organisations as ‘concerned parties’ in legislative processes and public administration. 
In the new regulation consumers were no longer seen as weak individuals in need of 
protection, but were called upon as competent and independent actors able to and 
responsible for making relevant choices in the food market. In order for consumers to be 
able to live up to this, full information about food products was necessary. This was the 
aim of legislation about labelling and traceability. In most countries the development 
towards the Single European Market and the need for national economies to adapt to it 
is an important driver behind regulatory and institutional change. Thus references to the 
new demands of traceability are frequently made in all countries, when discussions are 
raised about the need to adjust national food control policies to the EU system and adopt 
the principles of HACCP. It is thus clear that the regulatory changes following the new 
EU food policies in some countries are carried through on the initiative of private 
market actors, while in others, the state and the public authorities have acted as 
vanguard of the necessary reforms.  
 
1.1.6. Microbiological hazards 
Following the recommendations of the EFSA Committee on Veterinary Measures 
(SCVPH), and using the Codex Principles for the establishment and application of 
microbiological criteria (1997), a new legislation was enacted in 2006. This is 
Regulation 2073/2005/EC on microbiological criteria for foodstuffs. Regulation 
2073/2005/EC distinguishes between “food safety criteria” and “process hygiene 
criteria”. The food safety criterion is mandatory and defines “the acceptability of a 
product or a batch of foodstuffs applicable to products ready to be placed on the 
market”. The process hygiene criterion applies to the production process and is not 
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mandatory. The expectation, of course, is that given the mandatory nature of food safety 
criteria and assuming an adequate number of controls, process hygiene criteria will be 
established by default. The Annex to Regulation 2073/2005/EC specifies for several 
food categories a set of relevant criteria such as the microbiological limits, the 
analytical reference method, the sampling design and the frequency of sampling. In the 
majority of cases, the analytical reference method relies on ISO or EN standards (Giorgi 
and Lindner, 2009). 
Various types of microbiological hazards have been reported through the RASFF 
system, including bacteria, moulds, and viruses. Bacteria constitute the largest group of 
microbiological hazards, with more than a hundred specific microbe species, 
subspecies, and strains. The most important product categories are seafood, meat, 
poultry, spice and condiment, animal feed, and dairy products. As regards bacteria, 
Salmonella and its subspecies are the most numerous. Salmonella typhimurium, 
including the phage types DT104, DT108, and U302, mainly occur in meat and poultry; 
while Salmonella enteritidis mainly is reported as microbiological contaminations of 
egg products (Kleter et al., 2009). 
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1.2. FOODBORNE PATHOGENS OF INTEREST 
 
Many foodborne pathogens can have habitats in food-producing animals and in the farm 
environment. These pathogens can enter meat and milk products during slaughter or at 
milking, or can contaminate raw vegetables when soil is fertilized with improperly 
composted animal manure (McEwen and Fedorka-Cray, 2002). There is evidence to 
support the concept that significant increase in the incidence of foodborne illness is 
related to changes in animal husbandry practices and to the handling and processing of 
food of animal origin (Committee on the Review of the Use of Scientific Criteria and 
Performance Standard for Safe Food, National Research Council, 2003) 
Specific groups of disease-causing microorganism are consistently associated with the 
food-producing animal environmental. 
The results on the occurrence of zoonoses, zoonotic agents, antimicrobial resistance and 
foodborne outbreaks that were reported from the Member States and analysed by EFSA 
show that in 2005 the two most commonly reported zoonotic diseases in the European 
Union were campylobacteriosis and salmonellosis (Hugas and Tsigarida, 2008). 
From the standpoint of preharvest food safety in general and human health in particular, 
Salmonella spp., E. coli, Campylobacter jejuni, and Listeria monocytogenes are 
important foodborne pathogens affecting public health. These pathogens are the leading 
causes of foodborne morbidity and mortality, and they are carried by cattle, poultry, and 
swine and are found in their associated farm environments. Epidemiological data 
suggest that other pathogens, including Staphylococcus aureus, Clostridium 
perfringens, and Bacillus cereus are important pathogens that have origins on farms 
(Oliver et al., 2009). 
All these bacteria are the major pathogens of animal origin transmitted through food, 
and they are found in animal feces; therefore, contamination of carcasses and food 
products by animal feces is likely to be a principal mode by which foodborne pathogens 
reach the consumer. Cattle, sheep, swine, chicken, and turkeys are principal reservoirs, 
but wild birds and various mammals that are common in farm environments can be also 
a source of these pathogens (D’Aoust et al., 2008; Meng et al., 2008; Nachamkin, 2008; 
Swaminathan et al., 2008). The contamination cycle in food-producing animals is 
through ingestion of feed and water that can be contaminated by feces. The use of 
nontreated manure as fertilizer, the spread of slurry, and the use of recycled wastewater 
disseminate these pathogens even more. Stresses on animals caused by poor 
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management, types and quantities of feeds increase susceptibility to infection and 
shedding of foodborne pathogens (Cray et al., 1998). 
 
1.2.1. Foodborne pathogens: common characteristics and control strategies on 
farm 
Several epidemiological characteristics are common to foodborne pathogens of interest: 
• Foodborne pathogens are shed in feces and gastrointestinal secretions or 
excretions of healthy animals. Shedding is sporadic and is caused by reinfection 
from sources in the environment. 
• Cattle, swine, and poultry are believed to be the primary reservoirs, but birds 
and various mammals that are common in farm environments were also 
identified as reservoirs.  
• The contamination cycle is as follows: infection occurs initially by ingestion of 
contaminated feeds and water, followed by shedding of food pathogens in feces 
that, in turn, contaminate feeds and animal drinking water, causing new 
infections and reinfection of convalescent animals. 
• Stress caused by poor management and by the types and quantities of animal 
feedstuffs increases their susceptibility to infection and the shedding of 
foodborne pathogens. 
• Feeds and water contaminated with feces and secretions or excretions from 
animals are the vehicles for additional contamination in the environment, 
including other mammals, birds, and insects. The use of nontreated manure as 
fertilizer and the spread of slurry and recycled wastewater further disseminate 
contamination. 
The model in which the presence of pathogens depends on ingestion of contaminated 
feed, followed by amplification in animal hosts and fecal dissemination in the farm 
environment. Colonization of the gastrointestinal tract and amplification of E. coli 
O157:H7, Salmonella, C. jejuni, and L. monocytogenes appear to be required stages in 
the cell cycles. Shedding of foodborne pathogens in feces and distribution in the 
environment where food-producing animals live lead to animal reinfection and 
persistence of the pathogen on the farm (Olivier et al., 2009). 
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Production units are major reservoirs for foodborne pathogens, that can reach the human 
population by direct contact, ingestion of raw contaminated food, or contamination 
during the processing of milk. 
By breaking the infection-reinfection cycle, it is possible to reduce foodborne pathogen 
shedding and therefore the spread of foodborne pathogens among food-producing 
animals and in the farm environment. 
From a management point of view, it is practicable to focus on selected groups of 
pathogens. However, many of the pathogens are asymptomatic for the animal 
harbouring or shedding them. Previous experience in pathogen reduction strategies, 
pathogen eradication strategies, or both amply testifies that postharvest packing or 
processing in itself is not adequate to reduce the risk of food safety consistently. Many 
experts now believe that pathogen reduction and HACCP strategies have resulted in 
noticeable changes in food safety risk reduction. It is imperative that even if human 
pathogens cannot be completely eliminated preharvest, their intended reduction is a 
logical end point that could reduce morbidity and mortality (Olivier et al., 2009). 
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1.3. CLOSTRIDIUM SPP. IN FOODSTUFFS 
 
Anaerobic spore-forming bacteria spoil a wide range of foods including dairy products, 
meat and poultry products, fresh and canned fruits and vegetables, typically producing 
gas and/or putrid odours. A few of those species can cause illness. 
The species of the genus Clostridium most commonly involved in food-borne illness are 
Clostridium perfringens and C. botulinum. Intoxication due to C. perfringens is usually 
brief, self-limiting, and is rarely fatal. However, the neurotoxins of C. botulinum are 
among the most toxic naturally-occurring substances and cause severe food-borne 
illness, sometimes fatal, with symptoms continuing for several months. 
Clostridia occur commonly in soil, dust, the aquatic environment and in the intestines of 
animals. Consequently, C. perfringens and C. botulinum can be present in a wide range 
of foods. Good Agricultural Practices and Good Hygienic Practices contribute to 
reducing numbers of clostridia by minimising contamination with soil and animal faeces 
(Songer, 1996; García and Heredia, 2009). 
C. perfringens is commonly present in foods and ingredients, occasionally at hundreds 
per gram. C. botulinum is present less frequently, normally at a few spores per kg. 
Spores of both C. perfringens and C. botulinum can be eliminated from foods by 
heating. 
 
1.3.1. Clostridium perfringens as microbiological hazard 
Clostridium perfringens may be the most widely occurring pathogenic bacterium and is 
certain the most important cause of clostridial enteric disease in animal and potentially 
lethal foodborne diseases in humans, including food poisoning and necrotic enteritis in 
the 1940’s, since when outbreaks have been reported (Songer, 1996; EFSA, 2005; 
García and Heredia, 2009). Some types of C. perfringens (mainly type A) are 
consistently recovered both from the intestinal tracts of animals and from the 
environment, while others (types B, C, D, and E) are less common in the intestinal tracts 
of animals and can occasionally be found in the environment in areas where disease 
produced by these organism is enzootic (Songer, 1996) 
C. perfringens is a gram-positive, spore forming, anaerobic bacterium and natural 
inhabitant of soil and the intestinal tracts of several animals, including humans. The 
ubiquitous nature of this bacterium and its spores makes it a frequent problem for the 
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food industry and establishments where large amounts of food are prepared because it 
grows well on meat and poultry products (García and Heredia, 2009; Golden et al., 
2009; EFSA, 2005). 
 This bacterium could be controlled properly following safety rules such as adequate 
heating and cooling of food during processing. 
The genus Clostridium consists of a diverse group of bacteria that are unable to grow in 
the presence of oxygen and have the ability to form heat-resistant endospores. This 
bacterium is the most prolific toxin-producing species within the clostridial group 
(Songer, 1996; García and Heredia, 2009). 
Food poisoning from C. perfringens gives rise to abdominal pain, nausea and acute 
diarrhoea 8-24 h after the ingestion of large numbers of the organism, a proportion of 
which survive the acid conditions of the stomach. The illness is usually brief and full 
recovery within 24-48 h is normal. However, death occasionally occurs in the elderly or 
otherwise debilitated patients (Songer, 1996; EFSA, 2005; García and Heredia, 2009). 
C. perfringens food poisoning is not a reportable disease; however, in the United States, 
the Center for Disease Control and Prevention (CDC) estimates that 250,000 cases of C. 
perfringens type A food poisoning occur annually (García and Heredia, 2009; Golden et 
al., 2009). 
The symptoms of the disease are caused by an enterotoxin. C. perfringens is grouped 
into 5 types A-E according to the exotoxins (soluble antigens) produced. Types A, C 
and D are pathogens for humans, types B, C, D and E, and possibly A also, affect 
animals. The enterotoxin produced by types A and C is distinct from the exotoxins and 
is responsible for the acute diarrhoea that is the predominant symptom of C. perfringens 
food poisoning (Songer, 1996; EFSA, 2005; García and Heredia, 2009). 
The beta-toxin of type C appears to be the necrotic factor in the disease enteritis 
necroticans jejunitis ("pig-bel"). Type A strains are responsible for gas gangrene 
(myonecrosis), necrotizing colitis, peripheral pyrexia, septicaemia as well as food 
poisoning. The enterotoxin involved in food-poisoning have been reviewed (Songer, 
1996; EFSA, 2005; García and Heredia, 2009). 
The disease-causing enterotoxin of C. perfringens (CPE) is produced during 
sporulation. To cause disease vegetative cells of C. perfringenes have to be ingested 
with the food. The vegetative cells that survive the acidity of the stomach sporulate in 
the intestinal lumen. During lysis of the mother-cells to release the spores, CPE is also 
released. Subsequently, the CPE is converted to a more active toxin by trypsin and 
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chymotrypsin, after which it binds to receptors present on the brush-border membrane 
of the intestinal epithelial cells (Songer, 1996; EFSA, 2005). The bound CPE inserts 
into the cell membrane and pores are produced that makes the cells permeable for ions 
and small molecules. As a consequence a reversal of ileal transport of water is induced 
(Songer, 1996; EFSA, 2005). 
It is important to recognise that not all C. perfringens are able to produce the 
enterotoxin that causes foodborne disease. Foodborne illness is caused when food 
becomes contaminated with large numbers of vegetative bacterial cells (>106 CFU/g) of 
C. perfringens type A isolated that carry the cpe gene (EFSA, 2005; García and 
Heredia, 2009; Golden et al., 2009). 
C. perfringens is ubiquitous and widely distributed in soil, dust, vegetation and raw 
foods. It is part of the normal flora of the intestinal tract of man and animals. Although 
the clostridia are anaerobes, C. perfringens is one of the less fastidious species and is 
able to grow under conditions that are not strictly anaerobic (Songer, 1996). The spores 
exhibit a range of resistance to heating, and spores of some strains readily survive 
cooking. 
C. perfringens type A food poisoning usually results from either improper cooling or 
temperature maintenance of food, preparation of food a day or more in advance, or 
inadequate reheating of food. Although C. perfringens spores are the main source of 
concern in food products, vegetative cells may occasionally cause health problems in 
nonheat-treated foods or by recontamination of heat-treated foods (García and Heredia, 
2009; Golden et al., 2009). To limit the growth of C. perfringens on meat and poultry 
products, the Food Safety Inspection Service (FSIS) published a final rule that 
establishment a performance standard for C. perfringens during production of RTE/PC 
food (Golden et al., 2009). 
C. perfringens can be detected in a wide range of foods as a result of contamination by 
soil or with fecal matter e.g. meat, poultry, fish, vegetables, dairy products, dehydrated 
foods such as soups and gravies, spices, milk, gelatin, pasta, flour, soy protein and 
animal feeds. 
Animal carcasses and cuts of meat can become contaminated with C. perfringens from 
contact with soil or animal feces, or during slaughtering and processing. Many 
organisms that compete with C. perfringens are killed when meat and poultry are 
cooked, but C. perfringens spores are difficult to eliminate (García and Heredia, 2009; 
Golden et al., 2009). 
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Illness occurs after ingestion of large numbers of enterotoxin-producing vegetative cells 
of C. perfringens, some of which survive the acid conditions of the stomach and 
subsequently form spores in the large intestine, at the same time producing enterotoxin. 
From reported and investigated outbreaks, approximately 108 vegetative cells per 
serving are necessary to cause diarrhoea. This occurs a few hours after consuming food, 
usually cooked meat or gravy, in which multiplication of C. perfringens has occurred 
and vegetative cells are present. The illness commonly lasts only ca 12-24 h, and the 
symptoms are usually not serious enough to consult a physician – hence the recorded 
number of outbreaks may be an underestimate.  
C. perfringens has the capacity to grow in protein-rich foods held at temperatures above 
12°C. Not all strains of C. perfringens have the capacity to produce enterotoxin. Cooked 
meat and poultry are the foods most commonly involved in C. perfringens food 
poisoning outbreaks. Fish and fish products are rarely implicated. 
C. perfringens requires more than a dozen amino acids and several vitamins for its 
growth, both of which are typically present in meat. The leading food vehicles for this 
bacterium in the United States are meats, notably beef and poultry, and meat-containing 
products, such as gravies, stews, and Mexican food. Ready-to-eat and partially cooked 
(RTE/PC) meat and poultry products were the focus of the risk assessment, too (García 
and Heredia, 2009; Golden et al., 2009). 
C. perfringens type A food poisoning usually results from either improper cooling or 
temperature maintenance of food, preparation of food a day or more in advance, or 
inadequate reheating of food (García and Heredia, 2009; Golden et al., 2009).  Almost 
all outbreaks are the result of cooling slowly, or holding without refrigeration, allowing 
multiplication of C. perfringens, numbers reaching 106-107 cells/g, implying an 
infective dose of the order of 108 vegetative cells of enterotoxin-producing C. 
perfringens (EFSA, 2005). 
Occasionally illness has been caused by pea soup prepared on a catering (food service) 
scale. Even after slow cooling and multiplication of C. perfringens that survives 
cooking; thorough re-heating will inactivate the vegetative cells and prevent illness. In 
the Netherlands, pea soup is traditionally composed of cut vegetables (peas, celery, 
leek, and carrots) and pork meat. It has a neutral pH. It is usually produced in winter 
and often in large quantities e.g. at sporting events (EFSA, 2005). 
Although C. perfringens spores are the main source of concern in food products, 
vegetative cells may occasionally cause health problems in nonheat-treated foods or by 
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recontamination of heat-treated foods (García and Heredia, 2009; Golden et al., 2009). 
To limit the growth of C. perfringens on meat and poultry products, the Food Safety 
Inspection Service (FSIS) published a final rule that establishment a performance 
standard for C. perfringens during production of RTE/PC food (Golden et al., 2009) 
 
Risk factors 
C. perfringens posses several attributes that have contributed significantly to its ability 
to cause foodborne illness. First of all, It has an ubiquitous distribution in the natural 
environment and it is present in most raw food product materials, including vegetables 
and meat products. Therefore, its presence in many food products must be accepted., 
giving it ample opportunity to contaminate food. Overall, it has the ability to form heat-
resistant spores. In second time, C. perfringens has the ability to grow quickly in foods, 
allowing the bacteria to reach the high levels that are necessary for food poisoning. 
Finally, C. perfringens is capable of producing an intestinally active enterotoxin (CPE) 
that is responsible for the characteristic gastrointestinal symptoms of C. perfringens 
food poisoning (Songer, 1996; García and Heredia, 2009). 
The extent of multiplication of C. perfringens in food is determined mainly by the 
storage temperature. In addition, C. perfringens requires a protein-rich substrate for 
growth, explaining why foods associated with C. perfringens outbreaks are limited to 
meat and poultry products, gravy, casseroles and pea soup, usually after temperature-
abuse after cooking. Low numbers of C. perfringens spores often survive cooking and 
multiply to food- poisoning levels during slow cooling and unrefrigerated storage of 
prepared foods. Larger quantities of food, large joints of meat, and large containers of 
pea soup are difficult to cool quickly. Hence cooling rate and temperature of storage are 
risk factors. 
Herbs, spices and seasonings may contain C. perfringens in numbers varying from <100 
- 500/g (Songer, 1996; EFSA, 2005; García and Heredia, 2009). Use of herbs and spices 
is considered by some to be a risk factor. However, there is no evidence that adding 
even substantial amounts of herbs and spices to cooked foods is a real risk factor for C. 
perfringens-induced disease. Herbs and spices containing C. perfringens will only cause 
disease if the cooked food in question is not cooled adequately or left-overs are not 
reheated sufficiently (70-72°C throughout) and is therefore only a temperature-related 
risk factor (EFSA, 2005). 
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Initial contamination of food 
The initial contamination of foods with C. perfringens is difficult to control. While 
Good Agricultural Practices (GAP) can help to reduce numbers of infectious pathogens 
such as salmonellae, the only means of reducing the initial load of bacterial spores is to 
minimise contamination of raw foods by soil and by animal faeces. Good Hygienic 
Practices (GHP) in the manufacturing environment minimise chances of 
recontamination. There is some evidence that C. perfringens can reside in pipelines and 
contaminate product, resulting in spoilage of the product (EFSA, 2005). 
Because C. perfringens occurs so commonly in the environment, many foods will be 
contaminated. Experience has demonstrated that if foods are handled properly during all 
stages of distribution, retailing and consumer use, the likelihood of multiplication of 
clostridia is very low. Heating food to 68-70°C kills vegetative cells but not spores 
(Songer, 1996; EFSA, 2005; García and Heredia, 2009; Golden et al., 2009). 
 
Growth limitation of C. perfringens in the food chain 
There are numerous publications illustrating the importance of rate of chilling and 
holding temperatures on growth of C. perfringens (Songer, 1996; EFSA, 2005; García 
and Heredia, 2009; Golden et al., 2009). The optimum temperature for growth of C. 
perfringens is 43-47°C. Growth does not occur below 10-12°C. Most meat and poultry 
products receive a cook much lower than the sterilizing process for low-acid canned 
foods, and spores of C. perfringens survive. If the product then cools slowly, surviving 
spores germinate and multiply rapidly. After heating, meat and poultry products should 
be cooled from 55°C to below 15°C as quickly as is reasonably possible. US regulations 
serve as a guide, requiring the product’s internal temperature not to remain between 
54.4°C and 26.7°C for more than 1.5 h or between 26.7°C and 4.4°C for more than 5 h 
(FSIS, 1999).  
However, study of C. perfringens in commercially cooked products during chilling and 
refrigerated storage concluded that the above chilling regimes are more severe than 
necessary to maintain safe product (EFSA, 2005; Golden et al., 2009). 
 
Inactivation of clostridia in the food chain 
Heating is the most reliable method of inactivating bacterial spores. The rate of 
inactivation of spores is dependent on the temperature of heating, spores dying more 
rapidly as temperature rises. The heat resistance of spores is also affected by properties 
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of food (pH, water activity, fat content). Spores are more heat resistant at low aw and 
neutral pH values. Spores are more heat sensitive at low pH values (below ca pH 4.5); 
hence canned fruits are made safe and shelf-stable without refrigeration by much lower 
heat processes than those applied to low acid canned foods. (EFSA, 2005). 
Until 20-25 years ago inactivation of microbes in food processing used heating. Today 
many novel processes are being explored e.g. high hydrostatic pressure, pulsed 
electrical fields, irradiation used alone, or in combination with heat (EFSA, 2005). 
Several chemical and physical stresses can inactivate vegetative cells of Clostridium 
spp. and a proportion of their spores. Conditions in the food (pH, aw, fat content) may 
influence their effectiveness. 
For many centuries the curing of meat and fish has relied upon curing salts to control 
the growth of C. perfringens. Concerns that sodium nitrite in meat products might result 
in the formation of carcinogenic N-nitrosamines and other nitrosated products led to 
extensive research, mainly in North America and Europe, to try to find alternatives to 
sodium nitrite and sodium nitrate. Some anti-clostridial activity was identified in 
potassium sorbate and certain polyphosphates, parabens, antioxidants, nisin, and sodium 
lactate when used in combination with other conditions (EFSA, 2005). 
Cured meat producers have minimised the risk of formation of nitrosamines by reducing 
the amount of nitrite used, and eliminating nitrate from most cured products. 
 
If contamination is on farm? 
Epidemiological data suggest that C. perfringens is an important pathogen that has 
origins on farms. So, contamination of carcasses is another important point to control 
(Oliver et al., 2009). Reduce presence of C. perfringens on farm means to prevent and 
reduce contamination of carcasses. 
There are many reports about different ways of controlling the number of C. 
perfringens. In most cases antibiotics or ionophores anticoccidials were used. Due to the 
development of antibiotic resistance, concern about the effect of growth promoting 
antibiotics in animal feed on public health, and the approaching ban of nutritional 
antibiotics from feed in the EU, we need alternative methods to control the proliferation 
of C. perfringens in the digestive tract of animals, in particular of poultry (Mitsch et al., 
2004). 
C. perfringens proliferation is associated to an enteric disease in poultry known as 
necrotic enteritis, that can be costly to both the economy and animal welfare. The 
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disease is also of significance in preharvest food safety as the use of dietary antibiotics 
has been considered a potential link to the emergence of antibiotic-resistant strains of 
zoonotic microorganism in food animals (Si et al., 2009). 
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1.4. SALMONELLA SPP. AND FOOD SAFETY 
 
Foodborne salmonellosis is responsible for over 600 deaths and 1,4 million illnesses in 
US annually (Dunkley et al., 2009). In 1999, 22% of all culture-confirmed Salmonella 
infected individuals were hospitalized. Salmonella have also been commonly associated 
with foods such as raw meat poultry, eggs, and dairy products and cause a large fraction 
of the food-related deaths in the US annually. In Europe, the number of human cases 
was reported to be greater than 100,000 in 1997. In the past few years, the incidence of 
salmonellosis has shown a significant decrease across Europe and in the US since 1996. 
Approximately 60% of human cases reported to the CDC in 2001 were caused by four 
serotypes including S. Typhimurium, S. Enteritidis, S. Newport, and S. Heidelberg 
(EFSA, 2007; Callaway et al., 2008; Dunkley et al., 2009). 
Salmonellosis remained the second most frequent zoonosis with 176,395 reported 
human cases despite a fall of 9.5 % to an incidence rate of 38.2 compared to 2004. 
Salmonella was most often reported from Member States for fresh broiler and pig meat 
where proportions of positive samples were detected up to 18%. The reported 
proportions of positive findings in bovine meat were generally lower than 2%. In table 
eggs, findings of positive Salmonella samples ranged from 0% to 6%, but over the past 
5 years an overall decreasing trend was observed. In animal populations, Salmonella 
was most frequently detected in poultry flocks. Particularly, the results of the mandatory 
control programme for Salmonella in breeding flocks (Gallus gallus) at European level 
indicated that 6% of the parent-breeding  flocks for laying hens and 5% of parent-
breeding flocks for broiler were infected with Salmonella (EFSA, 2007; Hugas and 
Tsigarida, 2008). 
Salmonella spp. have been linked with illness among many animal species and humans, 
and are one of the most commonly reported causes of human foodborne disease. 
Salmonella live in the intestinal tract of various animal species and therefore represent a 
major reservoir for human foodborne disease. 
Studies have shown that Salmonella infection may be present on farms in the absence of 
clinical disease. Healthy animals can become carriers and shed Salmonella for long 
periods. Humans become infected primarily through fecal contamination of food 
products or water; however, direct contact with infected animals is another source of 
contamination, especially for farm families. Many of the >2,500 Salmonella enterica 
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serotypes are isolated frequently from clinically infected animals. Salmonella enterica 
serovars Typhimurium, Enteritidis, Javiana, Hadar, Kentucky, and Anatum are among 
these serotypes, and Salmonella Typhimurium DT 104 is of particular concern to public 
health agencies because of its multiple antibiotic resistance genes. 
Because fecal shedding of Salmonella is one of the principal modes of on-farm 
contamination, the question of how fecal shedding can be reduced is very relevant to 
human health. Research has demonstrated that reduction of Salmonella fecal shedding 
in poultry and swine production units is possible through the modification of 
management practices. Several control points that could be important for on-farm 
reduction of Salmonella include the presence of carrier animals, the exposure of 
neonates to feces from sick animals, environmental hygiene, the use of recycled water, 
contaminated feeds, the use of contaminated water to irrigate forage crops, the 
spreading of nontreated manure, and infected birds and rodents (EFSA, 2007; Oliver et 
al., 2009). 
In 1980, WHO formulated three lines of defence for the control of Salmonella which are 
still valid and may be used for other zoonotic agents. The first line focuses on the 
control of Salmonella in the food producing animal; the second line of WHO 
recommendations refers to the prevention or reduction of contamination of the 
carcasses; the third line of defence concentrates on the prevention of contamination 
during the final preparation of the food by industry and consumer (Hugas and Tsigarida, 
2008). 
Salmonella are pathogens but can frequently live in animals as a transient member of 
the intestinal microbial population without causing disease. Thus, reliance on animal 
looking sick is not an effective indicator of Salmonella colonization. Food animals are 
the primary vector for transmitting salmonella to humans. Chickens, turkeys, and eggs 
can all be infected with Salmonella. The intestinal tracts of finishing and breeding swine 
as well as that of beef and dairy cattle can contain Salmonella. Further outbreaks of 
salmonellosis have been linked to improper pasteurization of dairy products or 
improperly cooked ground beef. Other routes of exposure of humans to Salmonella 
include water runoff from farms or swine effluent lagoons, and direct animal or fecal 
contact (Callaway et al., 2008). 
Thus, Salmonella are relatively widespread in the environment and within food animals, 
and attempts to understand and control this pathogen must be equally broad based. 
Because Salmonella can live undetected in food animals but still pose a risk to human 
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consumers, control strategies must be tailored to specific animal species yet be 
applicable to large numbers of animals (Callaway et al., 2008; Martín-Peláez et al., 
2008). 
 
1.4.1. What is Salmonella? 
Salmonella are gram-negative bacteria comprising 2 species and 6 subspecies; the most 
important of which is Salmonella enterica infection in humans causes severe illness and 
can be an intracellular pathogen. Salmonella enterica causes illness in humans by 
passing from the intestinal tract into the epithelium, where it causes inflammation and 
systemically releases an enterotoxin and a potent endotoxin. Salmonella exists in a 
typical fecal-oral life cycle, although it can be spread through the nasal cavity to the gut. 
Salmonella enterica comprises over 2,500 known serovars that are pathogenic to 
humans or animals. A Salmonella serotype would commonly be known simply as 
Salmonella Typhimurium, rather than as S. enterica enterica Typhimurium. Some 
serotypes, such as Typhimurium, can be utilitarian and infect many species of animals, 
including man (Callaway et al., 2008). 
Adaptation allows Salmonella to exist as a pathogen in a suitable host environment, or 
as a transient member of the gastrointestinal population in a less-than-ideal host 
environment. Some serotypes can live in food animals without causing illness; however, 
when host animals and their carried serotypes are consumed by humans, then foodborne 
illness can result. 
Although Salmonella serotype influences the extent and outcome of human illness, 
elimination or treatment strategies are not different between serotypes. 
Although the relative importance of serotype has been overstated in regard to the 
development of pathogen reduction strategies, serotype is still critical information to 
understand the spread of Salmonella through the food chain. In USA, over the past 5 
years, the number of Salmonella-positive samples in ground beef has decreased and the 
percentage of positive samples from broilers has increased. This increase in broilers has 
led to the 2006 implementation of a “Salmonella attack plan” by USDA Food Safety 
and Inspection Service that focuses on an increased sampling frequency in “dirty” 
plants (Callaway et al., 2008). 
Seasonality of fecal shedding is critical to understanding the flow of Salmonella through 
the food chain. There is a correlation between shedding in animals and human 
outbreaks. Shedding by food animals can approach zero during the winter months and 
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reaches its peak in summer and early fall especially in cattle and swine, and human 
outbreaks also peak during this period (EFSA, 2007; Callaway et al., 2008). 
Although a physical correlation to temperature exists, it must be noted that the internal 
temperature is not the sole source of the observed seasonality. Other potential factors 
for seasonality of pathogen shedding include thyroid hormones and melatonin level as 
reported by Edrington et al. (2006, 2007).  
 
Salmonella in farm environments 
Salmonella spp. can be found widely on farms of many types, including those for beef 
and dairy cattle, swine farrowing and finishing facilities, and poultry farms. The 
Salmonella isolates came from all materials examined on the farms. 
Illness from salmonellosis in the bovine is seen predominantly in young calves, 
although occasionally it seen in adult cattle as well. Salmonella have been isolated from 
the feces of healthy dairy cattle, where the pathogen may exist as a normal member of 
the gastrointestinal population or as a transient member of gastrointestinal microbial 
population. Cattle can carry many different serotypes of Salmonella. 
Swine can be asymptomatic reservoirs of foodborne pathogenic bacteria that are 
transmissible to humans via consumption of contaminated pork products or through the 
environment (Callaway et al., 2008). 
Salmonella infections in porcines damage both health and productivity. Intestinal 
infection results in the destruction or turnover of the intestinal mucosa, inducing 
inflammatory diarrhoea. Furthermore, antibiotic resistance in Salmonella species found 
in farm animals can lead to increased morbility and mortality, due to reduced efficacy of 
therapeutic antibiotics. Economic losses associated with Salmonella are not only due to 
infection in farm animals but also through entry into the human food chain, where they 
can cause zoonotic infections in humans (Martín-Peláez et al., 2008) 
Foodborne pathogenic bacteria such as Salmonella can persist in the environment or 
within a herd at subclinical levels for years. The most common Salmonella serotypes 
isolated from swine include Derby, Typhimurium, and Infantis (Si et al., 2006; 
Callaway et al., 2008). 
Salmonella infection of farm animals is from multiple source and also has the capacity 
to cause asymptomatic infections, thereby increasing dissemination. Feeding 
management strategies are capable to exerting some control on Salmonella infection 
(Martín-Peláez et al., 2008) 
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Pigs may become colonized with Salmonella by ingesting contaminated feces. Placing 
swine in Salmonella-contaminated pens for a large period before slaughter can also 
result in the colonization of pigs immediately before entry into the food chain (Callaway 
et al., 2008). 
Salmonella is found commonly in chickens and turkeys, and it spreads easily from bird 
to bird through a fecal-oral route within poultry houses. Salmonella also can be spread 
via other reservoirs thus, the need for stringent biosecurity and pest control plans on 
most poultry farms.  
Salmonella Typhimurium an Enteritidis are the human illness-causing serovars most 
commonly associated with poultry meat and eggs. Both can cause illness in poultry and 
are isolated from clinically ill birds, but are frequently present as an asymptomatic 
infection, allowing them to enter the food chain without triggering a simple detection 
tripwire (Van Immerseel et al., 2006; EFSA, 2007; Callaway et al., 2008; Dunkley et 
al., 2009). 
Salmonella is a serious threat to broiler and egg production, both as a direct food safety 
threat in poultry meat and eggs and via vertical transmission to a new generation of 
infected broilers or layers. Because Salmonella can survive in the gut of birds or invade 
host tissues, it can be transmitted to consumers through various routes. For example, S. 
Enteritidis can invade the ovaries and be directly encapsulated in eggs, or it can live in 
the intestinal tract and enter eggs through cracks in the shell as the egg intersects the 
intestinal tract in addition to being transmitted through poultry meat. Fertilized eggs can 
be infected with Salmonella via semen. Thus, when an infected egg is hatched, the chick 
can already contain Salmonella, which can then be spread quickly to “clean” birds 
through contact, as well as through the common fecal-oral routes (Callaway et al., 2008; 
Dunkley et al., 2009). 
There has been a great deal of research aimed at understanding what effect stresses have 
on populations of Salmonella, especially dietary and transportation stresses (Callaway et 
al., 2008). Colonization of the gastrointestinal tract by pathogenic microorganisms is 
linked to environmental factors of the digesta and therefore, the composition and 
amount of ingested feed can influence colonization (Martín-Peláez et al., 2008). 
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1.5. FOOD PATHOGENS INTERVENTION AND REDUCTION 
STRATEGIES 
 
The ability of foodborne pathogens from food animals to be widely disseminated 
through the food chain, further emphasizing the need to reduce foodborne pathogenic 
bacteria in the live animal before they contact human consumers (Greathead, 2003; 
Burt, 2004; Diez-Gonzales, 2007; Oliver et al., 2009). 
With the growing industrialization of the production and transport of food, human 
illnesses from indirect contact have become increasingly noted. 
Some of the most promising improvements aimed at enhancing food safety have 
focused on the development of interventions that work at the live-animal level. Live-
animal, or on-farm, intervention strategies can be loosely grouped into 2 categories: 
procommensal strategies or directly antipathogen strategies (Diez-Gonzales, 2007; 
Oliver et al., 2009). 
Procommensal strategies use a native (or introduced) microbial ecosystem against 
pathogens by capitalizing on competition for nutrients and environmental niches. 
Directly antipathogenic strategies, on the other hand, specifically kill (or inhibit) 
pathogens via a variety of mechanisms. 
A procommensal strategy is defined as the establishment of a nonpathogenic microbial 
intestinal population that reduces, excludes, or kills pathogenic bacteria, including 
foodborne pathogens. Simply put, procommensal strategies promote the growth of 
groups of bacteria that are competitive with, or even antagonistic to, the pathogens of 
interest. Procommensal strategies used in food animals include probiotics, which are 
microbial cultures that are fed to animals to maintain a constant flow of commensal 
organisms through the gut environment; competitive exclusion, defined as the 
establishment of a microbial population in a naive food animal gut; and prebiotics. 
Antipathogenic strategies are the most straightforward of the intervention strategies 
because they directly attack the pathogen of interest. However, because foodborne 
pathogenic bacteria typically do not have any unusual properties within the gut of food 
animals, they are difficult to target directly without significant “collateral damage” on 
the rest of the microbial population. However, a variety of antipathogen strategies can 
be used to address pathogen populations in food animals, including antibiotics and 
bacteriocins, organic acids, and essential oil (Oliver et al., 2009). 
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Numerous nutritional additives are either already in use or have been proposed as means 
to reduce or eliminate pathogens or as a means to improve growth and feed conversion 
(Joerger, 2003; Diez-Gonzales, 2007). 
The primary mode of action of growth promoting feed additives arises from stabilizing 
feed hygiene (e.g., through organic acids), and even more from beneficially affecting 
the ecosystem of gastrointestinal microbiota through controlling potential pathogens. 
This applies especially to critical phases of an animals’ production cycle characterized 
by high susceptibility to digestive disorders, such as the weaning phase of piglets or 
early in life of poultry. Due to a more stabilized intestinal health, animals are less 
exposed to microbial toxins and other undesired microbial metabolites, such as 
ammonia and biogenic amines. Consequently, growth-promoting feed additives relieve 
the host animals from immune defence stress during critical situations and increases the 
intestinal availability of essential nutrients for absorption, thereby helping animals to 
grow better within the framework of their genetic potential (Windisch et al., 2008). 
 
1.5.1. Bacteriocins 
Bacteria have many complex mechanisms to resist antibiotics, and the widespread use 
of antibiotics in both human medicine and animal agriculture has led to the widespread 
dissemination of antimicrobial resistance genes. Because of concerns about the 
dissemination of antimicrobial resistance, it is likely that prophylactic use of medically 
important antibiotics as growth promotants in food-producing animals will become 
completely prohibited (Joerger, 2003; Diez-Gonzales, 2007; Oliver et al., 2009). 
Some bacteria produce proteinaceous compounds, known as bacteriocins, lethal to 
bacteria other than the producing strain, that can inhibit the growth of foodborne 
pathogenic bacteria, including C. botulinum, Bacillus spp., E. faecalis, E. coli, 
Salmonella, and Listeria (Carolissen-Mackay et al., 1997; Joerger, 2003; Diez-
Gonzales, 2007; Oliver et al., 2009). 
As with any antimicrobial compound, the issue of resistance also has to be considered 
for bacteriocins. Although the mechanism of action is not known for all bacteriocins, 
most of the low molecular weight bacteriocins appear to interact with the bacterial 
membrane. Resistance is therefore usually the result of changes in the membrane of 
bacteria targeted by a bacteriocin, but inactivation by degradation has been observed for 
nisin. Until recently, development of resistance to bacteriocins was not considered as 
affecting resistance to currently used antibiotics (Joerger, 2003; Oliver et al., 2009). 
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Compared to antibiotics, most bacteriocins are relatively specific and can only affect a 
limited number of bacterial species. Bacteriocins of lactic acid bacteria can be inhibitory 
to many Gram-positive organisms, but they have little effect on Gram-negative species 
due to the protective effect of the outer membrane. Among the different types of 
bacteriocins, colicins probably have the greatest specificity because many of them only 
affect strains within the same species. The specificity of bacteriocins can be particularly 
advantageous for applications in which a single bacterial strain or species is targeted 
without disrupting other microbial populations. In the case of pathogens as target 
organisms that colonize the gastrointestinal tract of poultry, cattle and swine, the use of 
bacteriocin-producing strains would have little effect on most beneficial intestinal 
bacteria (Joerger, 2003; Diez-Gonzales, 2007; Oliver et al., 2009). 
In contrast to the currently used antibiotics, bacteriocins are often considered more 
natural because they are thought to have been present in many of the foods eaten since 
ancient times. The bacteriocin nisin actually has GRAS (generally recognized as safe) 
status (Joerger, 2003; Oliver et al., 2009). Nisin and other bacteriocins produced by 
lactic acid bacteria have received a great deal of attention because they are produced by 
bacteria largely considered beneficial to human health and to food production (Joerger, 
2003). 
One of the potential benefits of using bacterocins in livestock is the stimulation of 
animal productivity. However, due to the specificity of bacteriocins it is very unlikely 
that their growth enhancement would be similar to the effect of antibiotics. In recent 
years, several reports have indicated that ruminal microorganisms are capable of 
producing a variety of bacteriocins and some of these organisms have been isolated for 
an eventual application to manipulate the rumen (Diez-Gonzales, 2007). 
The application of bacteriocin-producing bacteria for improvements in productivity has 
not been limited to cattle, as several researchers have explored the use of probiotic 
strains capable of producing bacteriocins to increase the growth rate of swine. In 
poultry, the use of bacteriocin has been mainly targeted for the control Salmonella. The 
potential improvement of productivity in animals mediated by the utilization of 
bacteriocin could be based on the inhibition of specific groups of organisms (Joerger, 
2003; Diez-Gonzales, 2007). 
The utilization of bacteriocin-producing bacteria as a pre-harvest food safety strategy is 
considered as one of the most viable interventions for reducing the gastrointestinal 
colonization of livestock by foodborne pathogens. These bacteria can easily be 
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administered to animals by mixing dried or wet cultures with feed or drinking water, 
and depending on the ability of the particular probiotics strain to colonize the 
gastrointestinal tract they could be fed sporadically or continuously. The feeding of 
bacteriocin-producing bacteria can have a direct effect on reducing the existing 
populations of foodborne pathogens such as Salmonella and Escherichia coli O157:H7, 
and long-term colonization with bacteriocin-producing bacteria would prevent further 
re-introduction of the pathogenic bacteria (Diez-Gonzales, 2007). 
Despite the enormous potential of bacteriocin-producing bacteria to increase animal 
productivity and to reduce the likelihood of foodborne disease, there are relatively few 
studies that have investigated the factors influencing their applicability (Diez-Gonzales, 
2007). 
The administration of bacteriocin-producing bacteria rather than the bacteriocins 
themselves might be a more cost-effective approach, but significant progress in 
developing suitable producer strains will have to be made before such an approach will 
be feasible. Few studies have addressed the fate of bacteriocins in the intestinal tract, 
but some data suggest that some of the low molecular weight bacteriocins can survive at 
least some of the intestinal environments and possibly could be administered with feed 
(Joerger, 2003; Diez-Gonzales, 2007). 
For uses involving purified bacteriocins, cost of the compounds can become a 
significant barrier. Production of all but the smallest bacteriocins is currently only 
imaginable by culture of natural or genetically engineered producer organisms (Joerger, 
2003). 
 
1.5.2. Organic acids 
Man has used fermentations as a method of food preservation for more than 6000 years, 
but now it appears that fermentation acids also have value as feed or drinking water 
additives. Commercial preparations appear to enhance digestibility and diet palatability, 
thus improving feed conversion and growth of animals, including pigs and poultry 
(Partanen and Mroz, 1999; Canibe et al., 2001; Hismiogullari et al., 2008; Van 
Immerseel et al., 2009). Some acid mixtures prevent mould growth on feed, and claims 
of increased egg production have been made. Pathogen control has also been reported, 
but the peer-reviewed scientific literature has few definitive studies (Canibe et al., 2001; 
Van Immerseel et al., 2009). Until recently, the use of short-chain fatty acids (SCFA), 
medium-chain fatty acids (MCFA) and other organic acids was largely based on their 
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antimicrobial activity outside the intestinal tract (Partanen and Mroz, 1999; Van 
Immerseel et al., 2009).  
Finally, organic acids (OA) acts as protectors of the gut, through very different ways, 
including mucosal growth, intestinal barrier function stregthening, anti-oxidant and anti-
infiammatory capacities, and anti-bacterial properties (Lallès et al., 2009). 
 
Bacterial metabolism of OA 
Bacteria can use organic acids as both carbon and energy sources. In E. coli, the 
hydrophobic long-chain fatty acids (LCFA) (≥C12) are transported across the cell 
membrane by carrier mechanisms, in which the fadL (outer membrane proteins) and the 
fadD proteins (inner membrane) are involved. FadL carries LCFA to the periplasmatic 
space and fadD is an acyl- CoA synthetase. Once the acyl-CoA molecules are formed 
inside the cell, degradation occurs through the b-oxidation pathway, yielding multiple 
acetyl-CoA molecules. Degradation of LCFA having an odd number of carbon atoms 
also yields propionyl-CoA as an end product. Whether MCFA (C6 to C10) can be 
transported by carrier proteins or are able to diffuse freely across the cell membrane in 
undissociated form is less clear, but also the fadD protein and the b-oxidation pathway 
are used for metabolization. The LCFA and MCFA can also be used for incorporation in 
the membrane as phospholipids. SCFA (≤/C4) presumably cross the outer membrane 
mainly through diffusion in the undissociated form. Once inside the cell, they can be 
converted to their CoA thioester forms. Butyric acid is converted to butyryl-CoA by the 
acetoacetyl-CoA transferase system (AtoAD system), converted to acetoacetyl- CoA by 
the fadB/E system, and then further breakdown to acetyl-CoA is performed by the atoB 
gene product (Van Immerseel et al., 2009). Thus as an example, butyric acid is 
converted to two molecules of acetyl-CoA. Propionic acid, either taken up from the 
environment or generated as an endproduct of degradation of LCFA with an odd 
number of carbon atoms is metabolized in Salmonella and E. coli in the methylcitrate 
cycle. Propionyl-CoA reacts with oxaloacetate to form 2-methylcitrate, which is 
converted through a series of reactions, to succinate and pyruvate. These products can 
be used in the citric acid cycle. Although it is thought that acetate can diffuse across the 
cell membrane, an acetate permease (ActP) was detected in E. coli. In E. coli and 
Salmonella, acetate is converted to acetyl-CoA by either acetyl-CoA synthetase or the 
sequential action of acetate kinase and phosphotransacetylase. Acetyl-CoA, generated 
by either the b-oxidation pathway, by butyric acid breakdown or by acetate conversion, 
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can be used for oxidation in the citric acid cycle and for replenishing intermediates of 
the citric acid cycle via the glyoxylate shunt (Van Immerseel et al., 2009). 
 
 
 
Figure 1.1. Chemical structures of main organic acids with antimicrobial activity. 
 
 
Meccanism of antimicrobial activity of OA 
Fermentative bacteria produce organic acids when oxygen is not available as a terminal 
electron acceptor, but they differ greatly in the types of acids that they produce. Because 
the oxidation of one molecule must be coupled to the reduction of another, anaerobic 
bacteria often produce several acids (Partanen and Mroz, 1999; Van Immerseel et al., 
2009). The simplest fermentation is conversion of sugar to lactate, and many 
lactobacilli, streptococci, lactococci and enterococci have a scheme that is virtually 
homolactic when sugar is plentiful. 
However, when sugars are scarce, all of these bacteria are capable of switching to a 
fermentation that produces acetate, formate and ethanol, so ATP production can be 
enhanced. 
Bacteria capable of utilizing fatty acids are found in stagnant anaerobic environments, 
but these bacteria grow very slowly, and fermentative environments are typically acidic. 
Fermentation acids are inhibitory when the pH is low but some bacteria are much more 
resistant than others. 
Traditionally, microbial growth inhibition by organic acids was explained by the ability 
of these acids to pass across the cell membrane, dissociate in the more alkaline interior 
and acidify the cell cytoplasm (Canibe et al., 2001; Van Immerseel et al., 2009). 
 
Citric acid Octanoic acid Lactic acid 
Sorbic acid Malic acid Benzoic acid 
Fumric acid 
Heptanoic acid 
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Organic acids were compared with synthetic uncouplers that could remain membrane 
associated, and shuttle protons in a cyclic manner to dissipate the proton-motive force. 
The problem with this analogy is the fact that organic acid anions are charged and not 
lipid permeable (Hismiogullari et al., 2008; Van Immerseel et al., 2009). 
 
Why are some bacteria so much more sensitive than others? 
For many years it was assumed that bacteria maintained a slightly alkaline intracellular 
pH, but this assumption was largely based on work with laboratory cultures of E. coli. It 
is now clear that many fermentative bacteria have the ability to let their intracellular pH 
decline when the extracellular pH becomes highly acidic. This decline in intracellular 
pH necessitates a metabolism that can tolerate a lower pH, but the strategy appears to be 
highly adaptive. When intracellular pH remains high, the pH gradient across the cell 
membrane can become very large. The protons can be pumped back out of the cell, but 
the pH gradient causes a logarithmic accumulation of the fermentation acid anions. By 
letting intracellular pH decrease, the bacterium has a much smaller pH gradient across 
the cell membrane and is protected from anion accumulation (Canibe et al., 2001; Mroz, 
2003; Van Immerseel et al., 2009). 
Fermentation acid anion accumulation was at least in part an osmotic stress. Recent 
work with C. sporogenes, a silage and food contaminant, indicated that it accumulated 
lactate anion at acidic pH values in accordance with the pH gradient across the cell 
membrane, but lactate anion accumulation caused a secondary effect. When lactate 
anion increased, the cells lost intracellular glutamate, and the fermentation scheme of 
amino acid deamination is dependent on glutamate transaminase. 
The lower the external pH, the more undissociated weak acid will be available (based 
upon pKa values) to cross the membrane and affect internal pH. To overcome the 
lowering of internal pH, several amino acid decarboxylases can be induced; these 
elevate the internal pH by consuming a proton during decarboxylation and they then 
exchange the decarboxulation end-product for a new substrate via a membrane-bound 
antiporter (Bearson et al., 1997). One example is lysine decarboxylase (CadA) coupled 
with the lysine-cadaverine antiporter (CadB) of S. Typhimurium. The CadA 
decarboxylates intracellular lysine to cadaverine and consumes a proton in the process. 
Cadaverine is then exchanged for fresh lysine from the surrounding environment via the 
CadB antiporter (Park et al., 1996). 
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The final result was a virtually complete inhibition of ammonia production (Van 
Immerseel et al., 2009). The antimicrobial activity of organic acids on other bacterial 
species has not been correlated with intracellular pH regulation, but bacteria that could 
be classified as neutrophils seem to be more sensitive than those that are acid tolerant. 
The anion model of organic acid toxicity explains why bacteria differ in their sensitivity 
to organic acids, but it does not provide information on the antibacterial effect of one 
acid versus another. 
Factors such as chain length, side chain composition, pKa values and hydrophobicity 
could affect the antimicrobial activity (Van Immerseel et al., 2009). 
 
1.5.3. Essential oil 
An essential oil is a mixture of fragrant, volatile compounds, named after the aromatic 
characteristics of plant materials from which they can be isolated. The term “essential” 
was adapted from the theory of “quinta essential” proposed by Paracelsus who believed 
that this quintessence was the effective element in a medical preparation (Greathead, 
2003; Lee et al., 2004). 
Essential oils are very complex mixtures of compounds and their chemical compositions 
and concentrations of individual compounds are variable. Because of the large variation 
in composition, the biological effects, if any, of essential oil may differ (Greathead, 
2003; Burt, 2004; Lee et al., 2004). 
Essential oil basically consist of two classes of compounds, the terpenes and 
phenylpropenes. Depending on the number of 5-carbon building blocks, terpenes can be 
sub-divided into mono-, sesqui-, and di-terpenes. Further derivates of terpenes are 
typified by the presence or absence of a ring structure, double bond, addition of oxygen 
or stereochemistry. Terpenes and phenylpropenes are synthesized by the mevalonic and 
shikimic pathway, respectively (Greathead, 2003; Lee et al., 2004). 
Essential oil, however, are a relatively new class of feed additives and we are still rather 
limited in knowledge regarding modes of their action and aspects of their application. 
Essential oils can be used as phytogenic feed additives incorporated into diets to 
improve productivity of livestock through amelioration of feed properties, promotion of 
the animals’ production performance, as well as improving quality of food derived from 
those animals (Greathead, 2003; Lee et al., 2004; Windisch et al., 2008). 
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Use of feed additives is usually subject to restrictive regulations. In general, they are 
considered as products applied by the farmer to healthy animals for a nutritional 
purpose on a permanent basis in contrast to veterinary drugs. 
In the European Union, for example, feed additives need to demonstrate identity and 
traceability of the entire commercial product, efficacy of the claimed nutritional effects 
including absence of possible interactions with other feed additives, as well as safety to 
the animal, to the user, to the consumer of animal-derived products, and to the 
environment. Problems with feed additive legacy may, therefore, arise especially with 
phytogenic feed additives addressed to explicit health claims or in case of plant derived 
substances suspected to modulate metabolism (Windisch et al., 2008). 
 
 
 
 
Figure 1.1. Chemical structures of  main substances of essential oil. 
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Antioxidative properties are well described for essential oil (Greathead, 2003; Lee et al., 
2004; Windisch et al., 2008). Among a variety of plants bearing antioxidative 
constituents, the volatile oils from the mint plants have been attracting the greatest 
interest, especially products from rosemary. Its antioxidative activity arises from 
phenolic terpenes. Other Labiatae species with significant antioxidative properties are 
thyme and oregano, which contain large amounts of the monoterpenes thymol and 
carvacrol (Windisch et al., 2008). 
The antioxidant property of many phytogenic compounds may be assumed to contribute 
to protection of feed lipids from oxidative damage like antioxidants usually added to 
diets (Greathead, 2003; Lee et al., 2004; Windisch et al., 2008). The principal potential 
of feed additives containing herbal phenolic compounds from Labiatae plant family to 
improve oxidative stability of animal derived products has been demonstrated for 
poultry meat, pork, rabbit meal, and eggs (Windisch et al., 2008). 
Phytogenic feed additives are often claimed to improve flavor and palatability of feed, 
thus, enhancing production performance (Greathead, 2003; Lee et al., 2004; Windisch 
et al., 2008). However, the number of studies having tested the specific effect of 
phytogenic products on palatability by applying a choice feeding design is quite limited. 
They show dose-related depressions of palatability in pigs fed essential oils from fennel 
and caraway, as well as from thyme and oregano herbs. On the other hand, there are 
numerous reports on an improved feed intake through phytogenic feed additives in 
swine (Windisch et al., 2008). 
A wide range of spices, herbs, and their extracts are known from medicine to exert 
beneficial actions within the digestive tract: stimulation of digestive secretions, bile, and 
mucus, and enhanced enzyme activity are proposed to be core mode of nutritional 
action (Greathead, 2003; Lee et al., 2004; Windisch et al., 2008). Phytogenic feed 
additives were also reported to stimulate intestinal secretion of mucus in broilers, an 
effect which was assumed to impair adhesion of pathogens and thus to contribute to 
stabilizing the microbial eubiosis in the gut of the animals. 
Herbs and spices are well known to exert antimicrobial actions in vitro against 
important pathogens (Windisch et al., 2008). The active substances are largely the same 
as mentioned previously for antioxidative properties, with phenolic compounds being 
the principle active components (Greathead, 2003; Burt, 2004; Lee et al., 2004; 
Windisch et al., 2008). The antimicrobial mode of action is considered to arise mainly 
from the potential of the hydrophobic essential oils to intrude into the bacterial cell 
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membrane, disintegrate membrane structures, and cause ion leakage (Greathead, 2003; 
Lee et al., 2004; Windisch et al., 2008). Microbiological analysis of minimum 
inhibitory concentrations (MIC) of plant extracts from spices and herbs, as well as of 
pure active substances, revealed levels that considerably exceeded the dietary doses 
when used as phytogenic feed additives (Burt et al., 2004; Windisch et al., 2008). 
Another implication of antimicrobial action of phytogenic feed additives may in be 
improving the microbial hygiene of carcasses. Indeed, there are isolated reports on the 
beneficial effects of essential oils from oregano on microbial load of total viable 
bacteria, as well as of specific pathogens (e.g., salmonella) on broiler carcasses 
(Windisch et al., 2008). 
Several are the effects of essential oil as growth promoters. Data on swine vary widely 
from depressions in production performance to improvements similar to those observed 
with common growth promoters, such as antibiotics, organic acids, and probiotics. For 
poultry, the majority of experimental results indicate reduced feed intake at largely 
unchanged weight gain or final body weight, leading to an improved feed conversion 
when feeding phytogenic compounds (Greathead, 2003; Lee et al., 2004; Windisch et 
al., 2008). Of course, the wide variation in biological effects induced by phytogenics 
reflects the experimental approaches to test suitability of these substances for use as 
growth promoting feed additives to swine and poultry and includes also failures in 
selecting proper plants, active components, and efficacious dietary doses. Recent studies 
with swine and poultry indicated stabilizing effects of phytogenic feed additives on the 
ecosystem of gastrointestinal microbiota. These effects are also typical for organic 
acids, which are known to exert a major part of their biological efficacy mainly through 
stabilizing the microbial eubiosis in the gastrointestinal tract. Morphological changes in 
gastrointestinal tissues due to phytogenic feed additives may provide further 
information on possible benefits on the digestive tract (Greathead, 2003; Burt, 2004; 
Lee et al., 2004; Windisch et al., 2008); however, the literature available does not 
provide a consistent picture. Available reports show increased, unchanged, and reduced 
villi length and crypt depth in the jejunum and colon for broilers and pigs treated with 
phytogenic feed additives. 
Improved digestive capacity in the small intestine may be considered an indirect side 
effect of feed additives stabilizing the microbial eubiosis in the gut. An improved 
prececal digestive capacity reduces the flux of fermentable matter into the hind gut and, 
thus, lessens the post-ileal microbial growth and the excretion of bacterial matter in 
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feces, respectively. Because bacterial protein is the dominant fraction of total fecal 
protein, an improved prececal digestive capacity may result indirectly in an increased 
apparent digestibility of dietary protein (Greathead, 2003; Lee et al., 2004; Windisch et 
al., 2008). 
Besides efficacy, application of phytogenic feed additives to livestock also has to be 
safe to the animal, the user, the consumer of the animal product, and the environment 
(Greathead, 2003; Lee et al., 2004; Windisch et al., 2008). Regarding exposed animals, 
adverse health effects cannot generally be excluded in case of an accidental overdose. 
For the user, the handling of pure formulations of such feed additives usually needs 
protective measures because they are potentially irritating and can cause allergic contact 
dermatitis (Burt, 2004; Windisch et al., 2008). With respect to consumer safety, the 
phytogenic feed additives cannot be relieved from determination of possible undesired 
residues in products derived from animals fed those products (Windisch et al., 2008). 
Phytogenic feed additives are claimed to exert antioxidative, antimicrobial, and growth 
promoting effects in livestock, actions which are partially associated with an enhanced 
feed consumption supposedly due to an improved palatability of the diet (Greathead, 
2003; Burt, 2004; Lee et al., 2004; Windisch et al., 2008). Whereas available results do 
not support a specific amelioration of palatability, the antioxidative efficacy of some 
phytogenic compounds to protect quality of feed, as well as that of food derived from 
animals fed those substances cannot be ruled out. With respect to antimicrobial action, 
some observations in vivo support the assumption for the general potential of 
phytogenic feed additives to contribute to a final reduction of intestinal pathogen 
pressure. When compared with antimicrobial feed additives and organic acids, the 
phytogenic substances currently used in practice seem to similarly modulate relevant 
gastrointestinal variables, such as microbial colony counts, fermentation products, 
digestibility of nutrients, gut tissue morphology, and reactions of the gut associated 
lymphatic system. In addition, phytogenic products may stimulate intestinal mucus 
production, which may further contribute to relief from pathogen pressure through 
inhibition of adherence to the mucosa (Windisch et al., 2008). 
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2. OBJECTIVES 
 
In the contest of improving food safety, as required by the European Authority and 
consumer, the attention was focused on microbiological risk in food animal. 
Clostridium perfringens and Salmonella spp. were the major causes of human infection. 
In particular, to prevent microbiological risk is necessary decrease slaughterhouse cross-
contamination. To obtain this result, the studies can be focused on the control of 
pathogens presence in  farm and reduction of intestinal tract colonization of swine and 
poultry. 
In this scenario the objectives of this work were: 
• to screen the antimicrobial power of different organic acids and flavours against 
foodborne pathogens, which represent a threat to both animal productivity and 
human health, to find possible synergisms among those compounds; 
• to evaluate the role of such compounds and their possible synergistic effect 
against pathogens in an in vitro system which simulate intestinal environment; 
• to evaluate natural compounds in vivo as feed additives to control pathogens 
infections. 
To reach these objectives 3 groups of experiments were planned: 
• determination of the Minimal Inhibitory Concentration (MIC). Study was 
planned to assess the MIC of organic acids and flavours against Clostridium 
perfringens and Salmonella Typhimurium, and find the presence of synergistic 
effects. 
• Intestinal fermentation. The study was to evaluate the role of association of 
organic acids and flavours to control Salmonella Typhimurium infection and 
modulate fermentation parameters in an in vitro system (batch culture 
techniques) that simulate swine intestinal environment. 
• In vivo studies. In the first study it was evaluate the role of microencapsulated 
blend of organic acids and flavours to control Clostridium perfringens infection 
in broilers; the second study was to evaluate the effect of a bacteriocin and its 
producer strain Pediococcus pentosaceus to reduce C. perfringens infection in 
broilers. 
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3. EVALUATION OF ANTIMICROBIAL ACTIVITY OF SEVERAL 
ORGANIC ACIDS AND FLAVORS AGAINST CLOSTRIDIUM 
PERFRINGENS AND SALMONELLA TYPHIMURIUM 
 
3.1. Aim of the study 
The antibacterial strength of such substances can be determined by broth dilution 
method and optical density measurement (Smith-Palmer et al., 1998), and the minimal 
inhibitory concentration (MIC) of a substance can be defined as the minimal 
concentration of such substance inhibiting visible growth of test organism used at a 
given infectious dose after a given amount of time (Karapinar and Aktug, 1987; 
Onawunmi, 1989; Hammer et al., 1999; Delaquis et al., 2002). 
Aim of the study was to evaluate of the capacity of some organic acids and flavors to 
control the growth of C. perfringens and S. Typhimurium, and the possible combination 
effect of a given organic acid and a given flavor to improve their individual antibacterial 
activities when combined at different concentrations during 24 h of incubation, in order 
to study their possible use in animal husbandry to reduce microbial infections and 
microbial carcass contamination at slaughter. 
 
3.2. Materials and method 
Bacterial strains and growth conditions 
The bacterial strains used to test the substances in this study were Clostridium 
perfringens ATCC 13124 and Salmonella enterica subs. enterica, serov. Typhimurium 
H2665 DT104. 
C. perfringens was stored in Cooked Meat (CM broth, Difco Laboratories, Division of 
Becton Dickinson and Company, Sparks, MD, USA) at room temperature. Clostridium 
working seeds were obtained by inoculating 100µL of stock culture in 10 mL of 
Reinforced Clostridial Medium (RCM) broth (Oxoid Spa, Bansingstoke, UK) and 
incubated at 37°C in anaerobic conditions through two subsequent incubations of 24h. 
S. Typhimurium was stored at –20°C in Brain Hart Infusion (BHI) broth with glycerol 
20% (v/v). The strain was revitalized by inoculation in BHI and incubation at 37 °C in 
aerobic conditions through two subsequent incubations of 24h. 
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Chemical substances 
Organic acids and flavours objects of the study were: thymol (Fluka), carvacrol (Fluka), 
vanillin (Fluka), limonene (Fluka), and lactic acid (Fluka), all purchased by Sigma-
Aldrich Chemie Gmbh, Steinheim, Germany, cinnamaldehyde, benzoic acid, citric acid, 
fumaric acid, and DL-malic acid (Sigma-Aldrich Corporation, St. Louis, MO, USA). 
The molecules were diluited in RCM broth for C. perfringens tests and in BHI broth for 
S. Typhimurium tests as described below (EP 1391155B1, Vetagro S.p.A, Italy) 
Broth dilution method 
Stock solutions of each acid were prepared by dissolving it in deionized water, 
correction to pH 6.5 followed by sterilization using a filter with a membrane pore size 
of 0.22 µm (Millipore Corporation, Bedford, MA, USA). 
Organic acid working solutions were prepared by serial two-fold dilutions of each stock 
solution with RCM or BHI broth (pH 6.5) in order to obtain the lowest concentrations to 
be tested depending on the type of acid.  
Flavor stock solutions were obtained by dissolving them in ethanol (≤ 5%, v/v) (Merck, 
Darmstadt, Germany) in order to reach 7.28 mM. All the solutions were adjusted to pH 
6.5 and sterilized by filtration (pore diameter 0.22 µm). Working broth solutions of each 
flavor were prepared by diluting them with RCM or BHI broth at pH 6.5 (flavor stock 
solution: RCM or BHI broth = 3: 1). Further concentrations were obtained in the same 
way until 1.96 mM was reached. Final concentrations tested in 96-wells microtiter 
plates were: 
• flavors (carvacrol, thymol, vanillin, cinnamaldehyde, and limonene) at: 1.82, 
1.46, 0.98, 0.73, 0.49 mM; 
• malic acid and lactic acid at: 500, 250, 125, 62.5, 31.25, 15.63 mM; 
• citric acid and benzoic acid at: 250, 125, 62.5, 31.25, 15.63, 7.82 mM; 
• fumaric acid at: 125, 62.5, 31.25, 15.63, 7.82, 3.91 mM 
Each flavor was tested alone and in combination with each organic acid at 
concentrations previously indicated. 
MIC determination in microtiter plates. 
Clostridium and Salmonella inhibition study was performed with 104 CFU/well: each 
well (96-wells microtiter plates) was filled with 100 µl of bacterial inoculum (105 
CFU/ml) and with 100 µl of each solution. The negative control  wells were inoculated 
in the same way with 100 µl of a 105 CFU/ml culture and 100 µl of RCM or BHI broth 
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(pH 6.5) without the addition of any substance. Each substance was tested two times per 
plate. 
A blank control with ethanol 5% (v/v) was assessed in order to verify that the highest 
concentration of ethanol used to dissolve flavors was not inhibiting the growth of 
bacteria. 
C. perfringens plates were incubated at 37 °C in anaerobic conditions, while S. 
Typhimurium plates were incubated at 37°C in aerobic conditions. Optical density (OD) 
as bacteria growth index was measured after 24h of incubation using a 
spectrophotometer (Tecan Spectra Classic, Tecan Group Ltd, Switzerland) at lambda (λ) 
= 630 nm. 
Broth turbidity at 104 CFU/mL could not be observed; increasing of turbidity was 
considered as a positive indicator of bacterial growth after 24h of incubation. For each 
bacterial strains the growth response was plotted against each concentration of the 
compounds. The minimal inhibitory concentrations (MIC) were determined as the 
lowest concentration of the substance tested which completely inhibited the increase of 
turbidity of bacterial cultures after 24h of incubation. 
To evaluate the effect of the combinations, the fractional inhibitory concentration (FIC 
index) was calculated for each substance in each combination (Ohran et al., 2005). The 
following formulas were used to calculate the FIC index:  
 
∑FIC = FIC A + FIC B, 
 
were FIC A was the ratio between the MIC of substance A in combination and MIC of 
substance A alone, and FIC B was the ratio between the MIC of the substance B in 
combination and MIC of substance B alone. Synergy was defined as a ∑FIC≤ 0.5; an 
additive effect was defined when  0.5< ∑FIC< 2. Indifference was defined as 
2<∑FIC<4, and antagonism was defined as a ∑FIC≥4. 
Statistical analyses 
The experiment was made in duplicate. For each bacterial strain, OD data were 
analyzed for each tested compound by One-way ANOVA; the differences among means 
of groups were obtained using Newman-Keuls t-test based on the variances derived 
from ANOVA (GraphPad Prism 4.0; GraphPad Software, San Diego, CA, USA). 
Differences were considered statistically significant at P<0.05. 
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3.3. Results 
Clostridium perfringens  
As described in table 3.1, MIC of carvacrol was 1.46 mM, even if at 0.98 mM carvacrol 
reduced C. perfringens growth of 84%. For organic acids were determined MIC value 
only for citric, benzoic and malic acid, 62.5 mM, 125 and 250 mM, respectively. For all 
the other acids MIC was not determined because the highest concentrations tested were 
not effective in inhibiting Clostridium growth. As showed citric acid was more effective 
against C. perfringens. Lactic acid showed to have inhibitory effect at high 
concentration during the 24h duration of the study (fig. 3.1). 
The MIC of combination showed that, even if any acid alone did not inhibit C. 
perfringens, the same acid in combination with carvacrol had an antibacterial activity, 
reducing bacteria growth.. Carvacrol at 0.98 mM instead of 1.46 mM, in association 
with fumaric acid at 125 mM. completely inhibited C. perfringens. 
As described by FIC index, there was an additive effect between carvacrol and citric, 
malic or benzoic acid. 
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Figure 3.1. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values. Cr= carvacrol; L= lactic acid. 
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Table 3.1. Antibacterial effect of carvacrol and organic acids alone or in combination, against 104 
CFU/ml of C. perfringens after 24h of incubation. MIC values are expressed as mM. (n=2). NI= Not 
Inhibitory. 
 
MIC Carvacrol MIC Citric MIC Carvacrol + Citric FIC 
0.98 + 7.82 0.8 
0.73 + 31.25 1.0 1.46 62.5 
0.49 + 31.25 0.8 
MIC Carvacrol MIC Malic MIC Carvacrol + Malic FIC 
0.98 + 31.25 0.8 
1.46 250 
0.73 + 125 1.0 
MIC Carvacrol MIC Benzoic MIC Carvacrol + Benzoic FIC 
0.98 + 62.5 1.2 
1.46 125 
0.73 + 62.5 1.0 
MIC Carvacrol MIC Fumaric MIC Carvacrol + Fumaric FIC 
1.46 NI 0.98 + 125 - 
MIC Carvacrol MIC Lactic MIC Carvacrol + Lactic FIC 
1.46 NI NI - 
 
 
 
 
MIC of thymol (tab. 3.2) was not determined because the highest concentrations tested 
were not effective in inhibiting Clostridium growth, but at 1.82 and 1.46 mM reduced 
clostridia growth of 80%. For organic acid MIC values were determined for malic 
(500mM) and benzoic (125 mM). When acids were associated with thymol MIC values 
were reduced. C. perfringens growth was inhibited by malic acid and thymol in 
combination at 125 and 0.98 mM, or at 250 and 0.73 mM, or at 250 and 0.49 mM, 
respectively, whereas thymol at 0.98 mM, 0.73 and 0.49 mM did not decrease optical 
density values. MIC of benzoic acid and thymol in combination was 62.5 and 0.98 mM, 
respectively. For citric acid MIC was not determined because the highest concentration 
tested was not effective in inhibiting Clostridium growth, but when used in association 
with thymol clostridia growth was inhibited at 125 and 0.98 mM, or 250 and 0.73 mM, 
for citric acid and thymol, respectively. MIC of fumaric or lactic acid with thymol was 
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not determined, even if figure 3.2 showed a reduction of growth when thymol was used 
in association at 1.82 mM, 1.46 or 0.98 mM. 
 
 
 
 
Table 3.2. Antibacterial effect of thymol and organic acids alone or in combination, against 104 CFU/ml 
of C. perfringens after 24h of incubation. MIC values are expressed as mM. (n=2). NI= Not Inhibitory. 
 
MIC Thymol MIC Citric MIC Thymol + Citric FIC 
0.98 + 125 
0.73 + 250 NI NI 
0.73 + 50 
- 
MIC Thymol MIC Malic MIC Thymol + Malic FIC 
0.98 + 125 
0.73 + 250 NI 500 
0.49 + 250 
- 
MIC Thymol MIC Benzoic MIC Thymol + Benzoic FIC 
NI 125 0.98 + 62.5 - 
MIC Thymol MIC Fumaric MIC Thymol + Fumaric FIC 
NI NI NI - 
MIC Thymol MIC Lactic MIC Thymol + Lactic FIC 
NI NI NI - 
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Figure 3.2. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values. T= thymol, F= fumaric acid; L= lactic 
acid. 
 
 
 
MIC of cinnamaldehyde (tab. 3.3) was 1.46 mM. For organic acid MIC values were 
determined for citric (31.25 mM), malic (250 mM) and benzoic (125 mM). When acids 
were associated with cinnamaldehyde MIC values were reduced. C. perfringens growth 
was inhibited by benzoic acid and cinnamaldehyde in combination at 31.25 and 0.73 
mM, respectively, whereas cinnamaldehyde at 0.73 mM did not decrease optical density 
values. MIC of lactic acid and cinnamaldehyde in combination was 250 and 1.82 mM, 
or 500 and 1.46 mM, respectively. When citric acid was used in association with 
cinnamaldehyde clostridia growth was reduced by 65% at 7.82 and 0.73 mM, or by 69% 
15.63 and 0.49 mM, for citric acid and cinnamaldehyde, respectively. MIC of fumaric 
acid with cinnamaldehyde was not determined, but bacteria growth was reduced at 62.5 
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and 0.98 mM, or 15.63 and 0.98 mM for fumaric acid and cinnamaldehyde, 
respectively. Even if for lactic acid MIC was not determined because the highest 
concentration tested was not effective in inhibiting Clostridium growth, figure 3.3 
showed a reduction of growth when cinnamaldehyde was used in association at 1.82 or 
1.46 mM, and for all combination with lactic acid at 500 mM. 
 
Table 3.3. Antibacterial effect of thymol and organic acids alone or in combination, against 104 CFU/ml 
of C. perfringens after 24h of incubation. MIC values are expressed as mM. (n=2). NI= Not Inhibitory. 
 
MIC Cinnamaldehyde MIC Citric MIC Cinnamaldehyde + Citric FIC 
1.46 31.25 NI - 
MIC Cinnamaldehyde MIC Malic MIC Cinnamaldehyde + Malic FIC 
1.46 250 NI - 
MIC Cinnamaldehyde MIC Benzoic MIC Cinnamaldehyde + Benzoic FIC 
NI 125 0.73 + 31.25 - 
MIC Cinnamaldehyde MIC Fumaric MIC Cinnamaldehyde + Fumaric FIC 
1.46 NI NI - 
MIC Cinnamaldehyde MIC Lactic MIC Cinnamaldehyde + Lactic FIC 
1.82 + 250 
NI NI 
1.46 + 500 
- 
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Figure 3.3. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values. Cn= cinnamaldehyde; L= lactic acid. 
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MIC of vanillin (tab. 3.4) was not determined because the highest concentration tested 
did not inhibit clostridia growth. For organic acid MIC values were determined for citric 
(62.50 mM), malic (250 mM) and benzoic (125 mM). When acids were associated with 
vanillin the effects on inhibition of clostridia were not significant. Only lactic acid in 
combination with vanillin at 250 or 500 mM (fig. 3.4) showed an inhibition of bacteria 
growth of 80%. 
 
Table 3.4. Antibacterial effect of thymol and organic acids alone or in combination, against 104 CFU/ml 
of C. perfringens after 24h of incubation. MIC values are expressed as mM. (n=2). NI = Not Inhibitory. 
 
MIC Vanillin MIC Citric MIC Vanillin + Citric FIC 
NI 62.50 NI - 
MIC Vanillin MIC Malic MIC Vanillin + Malic FIC 
NI 250 NI - 
MIC Vanillin MIC Benzoic MIC Vanillin + Benzoic FIC 
NI 125 0.73 + 31.25 - 
MIC Vanillin MIC Fumaric MIC Vanillin + Fumaric FIC 
NI NI NI - 
MIC Vanillin MIC Lactic MIC Vanillin + Lactic FIC 
NI NI NI - 
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Figure 3.4. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values. V= vanillin; L= lactic acid. 
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MIC of limonene and organic acids were not determined because the highest 
concentration tested not inhibited C. perfringens growth. There were no differences in 
bacteria growth between the several concentrations of limonene tested. Only benzoic 
acid in association with limonene showed a dose-dependent reduction of bacteria 
growth probably because of benzoic acid inhibitory effect (fig. 3.5). 
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Figure 3.5. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values. L= limonene; B= benzoic acid. 
 
 
 
S. Typhmurium 
MIC of carvacrol (tab. 3.5) was not determined because the highest concentrations 
tested were not effective in inhibiting Salmonella growth, but alone was responsible for 
a reduction of 60% in bacteria growth compared to control. For organic acid MIC value 
was determined only for benzoic at 62.5 mM. When carvacrol was associated with 
organic acid, Salmonella growth was inhibited as showed in table 3. In these cases 
Salmonella was inhibited at low acids concentration, while carvacrol concentration in 
association  was high: two MIC of citric acid and carvacrol in combination was 7.82 
and 1.82 mM, or 7.82 and 1.46 mM, respectively; one MIC of malic acid and carvacrol 
in combination was 15.63 and 1.82 mM, respectively; MIC of fumaric acid and 
carvacrol in combination was 3.91 and 1.82 mM, respectively. Citric and malic acids 
showed a Salmonella growth inhibition dose- dependent (fig. 3.6). 
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Table 3.5. Antibacterial effect of carvacrol and organic acids alone or in combination, against 104 
CFU/ml of S. Typhimurium after 24h of incubation. MIC values are expressed as mM. (n=2). ND= Not 
Inhibitory. 
 
MIC Carvacrol MIC Citric MIC Carvacrol + Citric FIC 
1.82 + 7.82 
1.46 + 7.82 
0.98 + 125 
1.46 + 25 
NI NI 
0.98 + 50 
- 
MIC Carvacrol MIC Malic MIC Carvacrol + Malic FIC 
1.82 + 15.63 
1.46 + 62.5 
0.98 + 250 
0.73 + 500 
NI NI 
0.49 + 500 
 
 
 
- 
MIC Carvacrol MIC Benzoic MIC Carvacrol + Benzoic FIC 
1.46 + 31.25 
NI 62.5 
0.98 + 31.25 
 
MIC Carvacrol MIC Fumaric MIC Carvacrol + Fumaric FIC 
NI NI 1.82 + 3.91 - 
MIC Carvacrol MIC Lactic MIC Carvacrol + Lactic FIC 
NI NI 1.46 + 500 - 
 
 
 
 
 
___________________________________________Minimal Inhibitory Concentration 
 50 
S. Typhimurium 24h
ctr
Cr
1.8
2
Cr
1.4
6
Cr
0.9
8
Cr
0.7
3
Cr
0.4
9
M 
50
0 
M 
25
0 
M 
 
12
5
M 
62
.
5 
M 
31
.
25
 
M 
 
15
.
63
 
Cr
1.8
2+
M5
00
Cr
1.8
2+
M2
50
Cr
1.8
2+
M1
25
Cr
1.8
2-M
62
.
5
Cr
1.8
2+
M3
1.2
5
Cr
1.8
2+
M1
5.6
3
Cr
1.4
6+
M5
00
Cr
1.4
6+
M2
50
Cr
1.4
6+
M1
25
Cr
1.4
6-M
62
.
5
Cr
1.4
6+
M3
1.2
5
Cr
1.4
6+
M1
5.6
3
Cr
0.9
8+
M5
00
Cr
0.9
8+
M2
50
Cr
0.9
8+
M1
25
Cr
0.9
8+
M6
2.5
Cr
0.9
8+
M3
1.2
5
Cr
0.9
8+
M1
5.6
3
Cr
0.7
3-M
50
0
Cr
0.7
3+
M2
50
Cr
0.7
3+
M1
25
Cr
0.7
3+
M6
2.5
Cr
0.7
3+
M3
1.2
5
Cr
0.7
3+
M1
5.6
3
Cr
0.4
9+
M5
00
Cr
0.4
9+
M2
50
Cr
0.4
9+
M1
25
Cr
0.4
9+
M6
2.5
Cr
0.4
9+
M3
1.2
5
Cr
0.4
9+
M1
5.6
3
0.0
0.5
1.0
1.5
doses of carvacrol (Cr) and/or malic acid (M), mM
a
bs
, 
63
0 
n
m
 
Figure 3.6. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values. Cr= carvacrol; C= citric acid; M= 
malic acid. 
 
 
 
 
As showed in table 3.6, MIC of thymol was 1.46 mM. For organic acids, only MIC of 
benzoic acid was determined at 62.5 mM. MIC of benzoic acid and thymol in 
combination was 31.25 and 0.98 mM, respectively. In this case FIC index was 
calculated and showed an additive effect between substances. Salmonella growth was 
inhibited by combination of high acids concentration and low thymol concentration: one 
MIC of malic acid and thymol in combination was 500 and 0.49 mM, respectively; MIC 
of lactic acid and thymol in combination was 500 and 0.98 mM, respectively. 
Even if citric acid alone did not determined an inhibition of bacteria, when used in 
association with thymol bacteria growth was inhibited at low concentration: MIC of 
citric acid and thymol in combination was 31.25 and 0.98 mM, or 62.5 and 0.73 mM, 
respectively. Citric and malic acids showed a Salmonella growth inhibition dose- 
dependent (fig. 3.7). 
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Table 3.6. Antibacterial effect of thymol and organic acids alone or in combination, against 104 CFU/ml 
of S. Typhimurium after 24h of incubation. MIC values are expressed as mM. (n=2). ND= Not Inhibitory. 
 
MIC Thymol MIC Citric MIC Thymol + Citric FIC 
0.98 + 31.25 
0.73 + 62.5 
0.73 + 50 
1.46 NI 
0.49 + 50 
- 
MIC Thymol MIC Malic MIC Thymol + Malic FIC 
0.98 + 125 
0.73 + 250 1.46 NI 
0.49 + 500 
- 
MIC Thymol MIC Benzoic MIC Thymol + Benzoic FIC 
1.46 62.5 0.98 + 31.25 1.2 
MIC Thymol MIC Fumaric MIC Thymol + Fumaric FIC 
1.46 NI NI - 
MIC Thymol MIC Lactic MIC Thymol + Lactic FIC 
1.46 NI 0.98 + 500 - 
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Figure 3.7. Absorbance (λ=630 nm) values of C. perfringens growth after 24h of incubation. Column 
bars indicate mean ± SD. Each column is the mean of two values T= thymol; C= citric acid; M= malic 
acid.. 
 
 
 
 
MIC of cinnamaldehyde was not determined because the highest concentration tested 
not inhibited Salmonella growth. For organic acids, MIC was determined for malic (500 
mM) and benzoic acids (125 mM). When cinnamaldehyde was associated with organic 
acids, Salmonella growth was inhibited as showed in table 3.7.  
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Table 3.7. Antibacterial effect of thymol and organic acids alone or in combination, against 104 CFU/ml 
of S. Typhimurium after 24h of incubation. MIC values are expressed as mM. (n=2). ND= Not 
Determined. 
 
MIC Cinnamaldehyde MIC Citric MIC Cinnamaldehyde + Citric FIC 
1.82 + 31.25 
1.46 + 7.82 
0.98 + 31.25 
NI NI 
0.73 + 125 
- 
MIC Cinnamaldehyde MIC Malic MIC Cinnamaldehyde + Malic FIC 
1.82 + 15.63 
1.46 + 125 
0.98 + 250 
NI 500 
0.73 + 250 
- 
MIC Cinnamaldehyde MIC Benzoic MIC Cinnamaldehyde + Benzoic FIC 
1.82 + 62.50 
NI 125 
0.73 + 62.50 
- 
MIC Cinnamaldehyde MIC Fumaric MIC Cinnamaldehyde + Fumaric FIC 
1.82 + 7.82  
NI NI 
1.46 + 125 - 
MIC Cinnamaldehyde MIC Lactic MIC Cinnamaldehyde + Lactic FIC 
1.82 + 31.25 
NI NI 
1.46 + 250 
- 
 
 
MIC of vanillin was not determined because the highest concentration tested not 
inhibited Salmonella growth. For organic acids, MIC was determined for malic (500 
mM) and benzoic acids (125 mM). When vanillin was associated with organic acids, 
Salmonella growth not showed a significant reduction.  
The same results were founded for limonene alone or in combination with organic 
acids. 
 
3.4. Discussion 
MIC at 24h were determined in experiments where OA and flavours were tested in 
combination against Clostridium perfringens and Salmonella Typhimurium. In 
particular, it was also possible to determine the MIC of substances that, when tested 
singularly, induced only a partial reduction in growth but not complete inhibition. 
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Substances that showed a MIC value when tested singularly, showed a reduction of the 
MIC value when tested in combination. 
At considered concentrations of OA or flavours, showed a MIC value higher than the 
MIC value detected when the same substance was tested in combination with organic 
acids or flavours, respectively. 
Carvacrol showed a higher inhibition of C. perfringens than thymol. Carvacrol showed 
a lower inhibition of Salmonella than thymol. 
When carvacrol was tested in combination with OAs the result was a higher inhibition 
of  C. perfringens and Salmonella than the inhibition induced by thymol in combination 
with the same organic acid. 
Several studies reported bactericidal activity of plant extracts and organic acids on 
spoiling bacteria, moulds, and on pathogens such as S. aureus, Salmonella spp., E. coli, 
Listeria monocytogenes (Burt and Reinders, 2003; Lee et al., 2004; Burt et al., 2005; 
Peñalver et al., 2005; Gutierrez et al., 2008), but few authors studied antimicrobial 
activity of natural substances against C. perfringens. 
Several studies disagree with the effects of flavours against gram-positive or gram-
negative bacteria. Same authors demonstrated that different structural and chemical 
composition of the cells wall of gram-positive bacteria results more sensitive to 
antimicrobials action than gram-negative bacteria (Nikaido and Varra, 1985; Lis-
Balchin, 2003). From data of Si et al. (2006) appears that flavours have a gram-negative 
bacteria specifically as target. 
In these MIC experiment carvacrol had a strong antimicrobial activity against both C. 
perfringens and Salmonella. Data were confirmed by authors that obtained the same 
carvacrol antimicrobial activity against both gram-positive and gram-negative bacterial 
pathogens (Dorman and Deans, 2000; Lambert et al., 2001; Peñalver et al., 2005). 
The hydrophobic constituents of essential oils are capable of accessing to the periplasm 
of gram-negative bacteria through the porin proteins of outer membrane (Helander et 
al., 1998). Carvacrol and thymol can disrupt the outer membrane of bacteria, causing 
the release of membrane-associated material from the cell to the external medium and 
an increased permeability of the nucleus. It is thought that membrane perforation or 
binding is the main mode of action of such compounds (Shapiro and Guggenheim, 
1995; Strauss and Hayler, 2001). Structural features such as the aromatic ring, or the 
presence of hydroxylic group (e.g. thymol and carvacrol) alter polarity and topography 
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of a molecule, therefore changing the affinity to different binding sites in the bacteria 
(Si et al., 2006). 
Even if carvacrol and thymol differ in the chemical structure only by the position of 
hydroxyl group, in the present study they showed a different antimicrobial action. 
Ultee et al. (2002) hypothesized that the hydroxyl group and the presence of a system of 
delocalized electrons are important for the antimicrobial activity of phenolic 
compounds, such as carvacrol and thymol. Such a particular structure would allow 
compounds to act as proton exchanger, thereby reducing the gradient across the 
cytoplasmic membrane. The resulting collapse of the proton motrice force and depletion 
of the ATP pool lead eventually to cell death. The presence of free hydroxylic group 
play an important role on antimicrobial activity of carvacrol and thymol (Ben Arfa et 
al., 2006). Other authors focused on the importance of position of the hydroxyl group. 
López et al. (2007) demonstrated the difference in activity between carvacrol and 
thymol against S. choleraesuis, and the position of the hydroxyl group seems to 
influence their activity against gram-negative bacteria. 
Cinnamaldehyde showed an antimicrobial activity when associated with organic acids. 
Although cinnamaldehyde is known to be inhibitive to growth of E. coli O157:H7 and 
S. typhimurium at similar concentrations to carvacrol and thymol, it did not disintegrate 
the outer membrane or deplete the intracellular ATP pool. The carbonyl group is 
thought to bind to proteins, preventing the action of amino acid decarboxylases in E. 
aerogenes (Burt, 2004) 
Vanillin and limonene did not showed a significant antibacterial effect alone or in 
combination with organic acids. 
Organic acids resulted less effective than flavours if tested at the same molar 
concentration. The mode of action of organic acids is primarly associated to the fact that 
undissociated organic acid can penetrate the bacteria cell wall and disrupt the normal 
physiology of bacteria pH sensitive (Gauthier, 2002). After the undissociated acid 
passed through the bacterial cell wall, it dissociates, because of the inner cell pH, 
releasing H+ and anion COO-. The internal pH decreases and because pH sensitive 
bacteria do not tolerate large variation of cytoplasmic pH values, a specific mechanism 
(H+-ATPase pump) acts to bring the pH inside the bacteria to a physiological level. This 
phenomenon requires energy and it can stop the growth of the bacteria or even kills 
them. A lower internal pH involves others mechanisms: inhibition of glycolysis, 
prevention of active transport, interference with signal transduction (Lambert and 
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Stratford, 1999; Gauthier, 2002). The anionic part of the acid is trapped inside the 
bacteria because it can not diffuse freely through the cell wall, and its accumulation 
becomes toxic (Roe et al., 1998). Different bacteria showed different levels of 
sensitivity to different organic acids under specific circumstances. 
The present study let us to conclude that the in vitro results of inhibition effect of a 
flavour, in particular carvacrol or thymol, and an organic acid in combination could be a 
promising strategy to reduce C. perfringens and Salmonella contamination. 
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4. ROLE OF SEVERAL ASSOCIATION OF ORGANIC ACIDS AND 
NATURE-IDENTICAL COMPOUNDS IN SWINE BATH-CULTURE 
TECNIQUES 
 
4.1. Aim of the study 
Purpose of this part of the study was to screen the role of citric and sorbic acids, thymol 
and carvacrol in modulating the intestinal microflora of pigs in an in vitro fermentation 
system (bath-culture techniques), which simulate the intestinal environment and 
microflora. In particular, the study focalized on the antimicrobial effects of these 
substances against S. Typhimurium. 
A two step procedure was applied: 
1. digestion of the feed through enzymatic reactions; 
2. fermentation of digested diet with intestinal content, substances under 
investigations, and S. Typhimurium. 
 
4.2. Materials and method 
Digestion 
A commercial standard diet for pigs was digested in vitro to simulate gastric and 
pancreatic digestion as described by Verveake et al. (1989).this was a stepwise 
procedure with an incubation of feed (25 g; particle size<1 mm) in 500 mL of pepsin 
solution (0.2% pepsin w/v, HCl 0.075 N; P7000 from porcine gastric mucosa; Sigma 
Chemical, St. Louis, MO, USA) in a shaking bath at 37°C for 4 h. at the end of the 4h 
incubation, the solution was adjusted to pH 7.5 with NaOH 0.1 N. in the second step, 
500 mL of a pancreatin-NaHCO3 mixture solution (10g/L w/v pancreatin of 1M 
NaHCO3; P1500 from porcine pancreas; Sigma Chemical, St. Louis, MO, USA) was 
added and the mixture was reincubated for 4 h at 37°C to simulate pancreatic digestion. 
Composition of the phosphate buffer solution was as follows: 26.2 mM Na2HPO4, 46.7 
mM NaHCO3, 3.3 mM NaCl, 3.1 mM KCl, 1.3 mM MgCl2, 0.7 mM CaCl2 (Martillotti 
et al., 1987). After enzymatic digestion, the preparation was centrifuged (3,000 × g, 10 
min, 4°C), washed twice with distilled water, recentrifuged (3,000 × g, 5 min, 4°C), and 
dried at 60°C overnight. The digested diet was used as the substrate in the in vitro 
fermentation studies. 
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Batch Culture Fermentations 
Within 20 min after slaughter of pigs (six animals, 10 months old, live weight 
approximately 160 kg) cecal content were collected and kept in a sealed nylon bag at 
39°C during transfer to the laboratory. Cecal content was diluited with buffer (1:3) and 
filtered through six layers of cheese cloth. The filtered liquid was used as inoculum. The 
buffer composition (McDougall, 1948) was as follows:  
9.8 g NaHCO3 + 0.57 g KCl + 0.079 g CaCl2•6H2O + 9.3 g Na2HPO4•12H2O + 0.67 g 
NaCl +  0.12 MgSO4•7 H2O in 1 L of distilled water. Buffer pH was then adjusted to pH 
6.7 by adding 3N HCl. The buffer solution kept at 39°C and flushed with CO2 for 20 
minutes before use. The inoculum was dispensed into five 10 mL glass syringes (5 mL 
of inoculum in each syringe) and five 50 mL vessels (previously flushed with CO2, 25 
mL of inoculum in each vessel) per treatment, containing 20 and 100 mg of pre-digested 
diet, respectively. Syringes and vessels were sealed and incubated at 39°C for 24 h. 
Two experiments were performed to evaluate the antimicrobial activity against 
Salmonella Typhimurium of natural compounds. In the first, batch culture fermentations 
were performed in order to evaluate several combined doses of citric acid and thymol, 
or citric acid and carvacrol. The second was performed to evaluate several combined 
doses of sorbic acid and thymol, or sorbic acid and carvacrol. 
In each experiment, eight dietary treatment were investigated in vessels. Of these, in 
both experiment, one was a control diet (CTR), and the other was a control diet 
inoculated with Salmonella Typhimurium H2662 DT104 (106 CFU/ml) (S). 
In the first experiment, dietary treatments investigated were Salmonella Typhimurium 
infected control diet added with: 
• citric acid and thymol (pH 6.7) at 62.50 and 2.72 mM, respectively (CT1); 
• citric acid and thymol at 31.25 and 1.36 mM, respectively (CT2); 
• citric acid and thymol at 15.63 and 0.68 mM, respectively (CT3); 
• citric acid and carvacrol (pH 6.7) at 62.50 and 2.72 mM, respectively (CC1); 
• citric acid and carvacrol at 31.25 and 1.36 mM, respectively (CC2); 
• citric acid and carvacrol at 15.63 and 0.68 mM, respectively (CC3). 
In the second experiment, dietary treatments investigated were Salmonella 
Typhimurium infected control diet added with: 
• sorbic acid and thymol (pH 6.7) at 25 and 2.72 mM, respectively (ST1); 
• sorbic acid and thymol at 12.50 and 1.36 mM, respectively (ST2); 
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• sorbic acid and thymol at 6.25 and 0.68 mM, respectively (ST3); 
• sorbic acid and carvacrol (pH 6.7) at 25 and 2.72 mM, respectively (SC1); 
• sorbic acid and carvacrol at 12.50 and 1.36 mM, respectively (SC2); 
• sorbic acid and carvacrol at 6.25 and 0.68 mM, respectively (SC3). 
Citric acid, sorbic acid, thymol, and carvacrol were purchased from Sigma-Aldrich 
(Chemie Gmbh, Steinheim, Germany). 
Gas production was measured as described by Mencke et al. (1979), using 10 mL glass 
syringes and recording the cumulative volume of gas produced every 30 min. In 
syringes treatments were the same of vessels, excepted for treatment S and all 
treatments were not infected with Salmonella. 
Samples of fermentation fluid were collected from each vessel at time 0, 4, 8, and 24 h 
after incubation in shaking bath for ammonia analysis and microbial counts of 
Salmonella; pH was determined at the end of the fermentation. 
Chemical analyses of fermentation fluid and bacterial counts. 
Ammonia in fermentation fluid and intestinal chymus was measured as described by 
Searcy et al. (1967).  
Viable counts of Salmonella in fermentation samples were measured by plating serial 
10-fold dilutions onto Brilliant Green Agar (OXOID, Bansingstoke, UK) according to 
he manufacturer conditions. There were five plate-replicates per treatment. Brilliant 
Green Agar were incubated for 24 h at 37°C under aerobic conditions. 
Statistical analyses. 
A modified Gompertz bacterial growth model (Zwietering et al., 1992) was used to fit 
gas production data. This model assumes that substrate levels limit growth in a 
logarithmic relationship (Schofield et al., 1994) as follows: 
 
V = VF exp { - exp [1 + (µm e/VF)(λ - t)]}, 
 
where symbols have the meanings assigned by Zwietering et al. (1990): V= volume of 
gas produced at time t, t= fermentation time, Vf= maximum volume of gas produced, 
µm= maximum rate of gas production, which occurs at the point of inflection of the gas 
curve and λ= the lag time; as the time-axis intercept of a tangent line at the point of 
inflection. 
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The duration of the exponential phase was calculated from the parameters of the 
Gompertz equation, as suggested by Zwietering et al. (1992) with the following: 
 
exponential phase (h) = VF /(µm e){ 1 – ln[(3 -√5)/2]}. 
 
Curve fitting was performed using the program GraphPad Prism 4.0 (GraphPad 
Software, San Diego, CA, USA). Total gas production, maximum rate of gas 
production, duration of the exponential phase, ammonia, pH, bacterial counts, and 
SCFA data were analyzed by ANOVA using GraphPad Prism 4.0 (GraphPad Software, 
San Diego, CA, USA) in a completely randomized design. Each syringe and vessel 
formed the experimental unit. The differences among means of groups were analyzed 
using the Newmann-Keuls test. Differences were considered statistically significant at 
P<0.05. 
 
4.3. Results  
First trial: citric acid and thymol or carvacrol 
Gas production curves were accurately described by the modified Gompertz model 
(r2=0.98). Gompertz growth model showed that compared to control, all the blends of 
citric acid and carvacrol (CC1, CC2, CC3), and the blend of citric and thymol at 62.5 
and 2.92 mM (CT1) and citric acid and thymol at 31.25 and 1.46 mM (CT2), 
significantly increased gas production by 60% (P<0.05) (tab. 4.1). 
Maximum rate of gas production was significant high (P<0.05) for all treatments with 
additives. 
The duration of the exponential phase did not exhibit any statistical difference. 
Results suggested that citric acid stimulates intestinal fermentation, probably acting as 
substrate of microflora. 
Ammonia concentration was measured in the fermentation fluid after 4 and 8h from the 
beginning of the experiment. After 4 and 8h of fermentation, no changes occurred in 
ammonia production (tab. 4.2). 
Measurements of fermentation fluid pH from each treatment were assessed at the end of 
the experiment. The blend of citric acid and carvacrol at 15.63 and 0.68 mM (CC3) 
showed a pH value lower compared to control (-2.28%, P<0.05). While the blend with 
citric acid and thymol at 62.50 and 2.72 mM (CT1) and citric acid and carvacrol at 
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62.50 and 2.72 mM (CC1) showed a pH value significantly higher compared to CTR 
(+2.28% and 1.88%, respectively, P<0.05). 
Microbial counts (tab 4.3) showed a significant lower number of Salmonella cells at 4 
and 8h only in CTR group , in which diet was not infected with Salmonella, compared 
to the other treatments (-30%, P<0.05). At 24h, Salmonella growth was significant 
lower for treatments with citric acid and carvacrol at 62.50 and 2.72 mM (CC1, -26%, 
P<0.05), and citric acid and carvacrol at 31.25 and 1.36 mM (CC2, - 46%, P<0.05), 
compared to CTR. Salmonella counts for S group was numerically lower at 24h 
compared to the same group at the other time-points.  
These results showed that carvacrol was more effective as antimicrobial additive, 
compared to thymol. 
 
 
 
 
 
Table 4.1. First trial. Modified Gompertz equation fitted to gas production data from the 24h in vitro 
incubation of swine intestinal inoculum. Values are indicated as means ± SD. Different letters within the 
same column are significantly different (P<0.05). CTR= basal diet; CT1= basal diet with citric acid at 
62.50 mM and thymol at 2.72 mM; CT2= basal diet with citric acid at 31.25 mM and thymol at 1.36 mM; 
CT3= basal diet with citric acid at 15.63 mM and thymol at 0.68 mM; CC1= basal diet with citric acid at 
62.50 mM and carvacrol at 2.72 mM; CC2= basal diet with citric acid at 31.25 mM and carvacrol at 
1.36 mM, respectively; CC3= basal diet with citric acid at 15.63 mM and carvacrol at 0.68 mM; Vf= 
maximum volume of gas produced (mL); µm= maximum rate of gas production (mL h-1); log phase= 
exponential phase (h). 
 
Treatment  Vf µm Log phase n 
CTR 2.94 ± 1.57 a 0.23 ± 0.11 a 11.80 ± 3.04 5 
CT1 7.74 ± 2.08 b 0.57 ± 0.15 b 9.83 ± 5.73 4 
CT2 6.21 ± 2.06 b 0.64 ± 0.18 b 8.76 ± 2.09 5 
CT3 5.23 ± 1.72 ab 0.51 ± 0.17 b 10.13 ± 4.87 5 
CC1 8.71 ± 0.79 b 0.67 ± 0.09 b 9.50 ± 5.58 4 
CC2 6.76 ± 2.04 b 0.69 ± 0.09 b 8.90 ± 2.51 5 
CC3 6.69 ± 2.45 b 0.76 ± 0.19 b 8.66 ± 3.79 5 
 
 
 
 
 
 
______________________________________________________In vitro fermentation 
 62 
 
Table 4.2. First trial. Ammonia values (mmol L-1) at 4 and 8h, and pH values at 24h of an in vitro 
incubation of swine intestine inoculum. Values are indicated as means ± SD. Different letters within the 
same column are significantly different (P<0.05). CTR= basal diet; S= basal diet infected with Salmonella 
Typhimurium (106 CFU/mL); CT1= infected basal diet with citric acid at 62.50 mM and thymol at 2.72 
mM; CT2= infected basal diet with citric acid at 31.25 mM and thymol at 1.36 mM; CT3= infected basal 
diet with citric acid at 15.63 mM and thymol at 0.68 mM; CC1= infected basal diet with citric acid at 
62.50 mM and carvacrol at 2.72 mM; CC2= infected basal diet with citric acid at 31.25 mM and carvacrol 
at 1.36 mM; CC3= infected basal diet with citric acid at 15.63 mM and carvacrol at 0.68 mM. 
 
 
Treatment 4h 8h pH n 
CTR 20.30 ± 2.67 22.50 ± 2.60 6.67 ± 0.09 b 5 
S 19.95 ± 4.29 23.24 ± 2.71 6.63 ± 0.07 b 5 
CT1 24.14 ± 4.14 26.86 ± 6.36 6.82 ± 0.02 c 5 
CT2 24.70 ± 2.22 29.35 ± 1.88 6.71 ± 0.01 b 5 
CT3 22.48 ± 2.00 24.55 ± 3.16 6.71 ± 0.04 b 5 
CC1 25.67 ± 4.47 29.12 ± 8.02 6.79 ± 0.06 c 5 
CC2 22.25 ± 4.35 24.29 ± 5.85 6.63 ± 0.03 b 5 
CC3 21.60 ± 2.29 29.22 ± 1.77 6.51 ± 0.03 a 4 
 
 
 
Table 4.3. First trial. Counts of Salmonella Typhimurium (log10 CFU mL-1) at 4, 8 and 24h of an in vitro 
incubation of swine intestinal inoculum.  Values are indicated as means ± SD. Different letters within the 
same column are significantly different (P<0.05). N.D.= under the detection limit. CTR= basal diet; S= 
basal diet infected with Salmonella Typhimurium (106 CFU mL-1); CT1= infected basal diet with citric acid 
at 62.50 mM and thymol at 2.72 mM; CT2= infected basal diet with citric acid at 31.25 mM and thymol at 
1.36 mM; CT3= infected basal diet with citric acid at 15.63 mM and thymol at 0.68 mM; CC1= infected 
basal diet with citric acid at 62.50 mM and carvacrol at 2.72 mM; CC2= infected basal diet with citric 
acid at 31.25 mM and carvacrol at 1.36 mM; CC3= infected basal diet with citric acid at 15.63 mM and 
carvacrol at 0.68 mM.  
 
Treatment 4h n 8h n 24h n 
CTR 4.84 ± 0.25 a 5 4.08 ± 0.92 a 5 3.17 ± 1.09 b 5 
S 6.72 ± 0.19 b 3 7.06 ± 0.08 b 3 4.00 ± 0.28 b 5 
CT1 7.53 ± 0.11 c 4 7.00 ± 0.14 b 3 4.77 ± 0.30 c 5 
CT2 7.10 ± 0.15 b 3 6.82 ± 0.20 b 5 4.21 ± 0.23 b 5 
CT3 7.06 ± 0.18 b 4 6.77 ± 0.21 b 4 3.55 ± 1.07 b 4 
CC1 6.98 ± 0.26 b 4 N. D. 5 2.94 ± 0.75 ab 4 
CC2 7.39 ± 0.32 c 5 6.84 ± 0.16 b 4 2.16 ± 0.25 a 5 
CC3 7.32 ± 0.32 c 3 6.66 ± 0.15 b 3 3.95 ± 0.20 b 3 
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Second trial: sorbic acid and thymol or carvacrol 
Gompertz growth model showed no statistically difference in gas production for the 
blends with sorbic acid and thymol (ST1, ST2, ST3) (tab. 4.4). 
The treatment with sorbic acid and carvacrol at 25 and 2.72 mM (SC1) showed a 
reduction in gas production compared to CTR and blend with the same concentration of 
sorbic acid and thymol (ST1) (-32% and -40%, respectively). 
Analysis of maximum rate of gas production reflected the same tendency of results 
obtained from analysis of gas volume. Treatment with sorbic acid and carvacrol at 25 
and 2.72 mM (SC1) exhibited a maximum rate of gas production significant lower 
respect to ST1 and CTR (-57%, P<0.05). 
The duration of exponential phase of the blend with sorbic acid and carvacrol at 25 and 
2.72 mM was significant higher then CTR (+74%, P<0.05). 
However results suggest that blend of sorbic acid and carvacrol at 25 and 2.72 mM 
(SC1) slowed down metabolic activity of bacteria, enhancing the duration of 
exponential phase, and decreasing gas production. 
Ammonia (tab. 4.5) concentration was significantly increased after 4h by SC1 compared 
to CTR (+47%, P<0.05); after 8h ammonia concentration was significant enhanced by 
SC1 and ST1 when compared to CTR (+29% and +42%, respectively, P<0.05). 
The treatments with sorbic acid and thymol at 25 and 2.72 mM and at 12.50 and 1.36 
mM significantly lowed pH values when  compared to control (6.6 versus 6.9, for ST1 
and ST2 versus CTR, respectively, P<0.05). 
Microbial counts after 4, 8, and 24h showed no significant difference among treatments 
(tab 4.6). After 4h, there were no difference between treatments with lower 
concentration of both essential oil (ST3 and SC3) and treatment with Salmonella 
infected control diet (S); while blends with thymol at 2.72 and 1.36 mM (ST1 and ST2, 
respectively) reduced Salmonella growth by 11%. 
Microbial counts showed that only the blend with sorbic acid and carvacrol at 25 and 
2.72 mM (SC1) inhibited Salmonella growth during 24h of fermentation. 
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Table 4.4. Second trial. Modified Gompertz equation fitted to gas production data from the 24h in vitro 
incubation of swine intestinal inoculum. Values are indicated as means ± SD. Different letters within the 
same column are significantly different (P<0.05). CTR= basal diet; ST1= basal diet with sorbic acid at 
25 mM and thymol at 2.72 mM; ST2= basal diet with sorbic acid at 12.50 mM and thymol at 1.36 mM; 
ST3= basal diet with sorbic acid at 6.25 mM and thymol at 0.68 mM; SC1= basal diet with sorbic acid at 
25 mM and carvacrol at 2.72 mM; SC2= basal diet with sorbic acid at 12.50 mM and carvacrol at 1.36 
mM, respectively; SC3= basal diet with sorbic acid at 6.25 mM and carvacrol at 0.68 mM; Vf= maximum 
volume of gas produced (mL); µm= maximum rate of gas production (mL h-1); log phase= exponential 
phase (h). 
 
Treatment  Vf µm Log phase n 
CTR 5.09 ± 0.47 ab 0.49 ± 0.05 b 9.43 ± 1.17 a 5 
ST1 5.84 ± 0.41 b 0.49 ± 0.10 b 8.84 ± 5.24 a 4 
ST2 5.19 ± 0.51 ab 0.52 ± 0.02 b 9.03 ± 0.93 a 5 
ST3 4.87 ± 0.52 ab 0.46 ± 0.03 b 9.63 ± 1.14 a 5 
SC1 3.46 ± 0.82 a 0.21 ± 0.12 a 16.43 ± 4.68 b 5 
SC2 5.46 ± 0.44 b 0.45 ± 0.04 b 10.83 ± 0.39 a 5 
SC3 4.17 ± 2.07 ab 0.48 ± 0.22 b 8.33 ± 3.31 a 5 
 
 
 
 
 
 
Table 4.5. Second trial. Ammonia values (mmol L-1) at 4 and 8h, and pH values at 24h of an in vitro 
incubation of swine intestine inoculum. Values are indicated as means ± SD. Different letters within the 
same column are significantly different (P<0.05). CTR= basal diet; S= basal diet infected with Salmonella 
Typhimurium (106 CFU/mL); ST1= infected basal diet with sorbic acid at 25 mM and thymol at 2.72 mM; 
ST2= infected basal diet with sorbic acid at 12.50 mM and thymol at 1.36 mM; ST3= infected basal diet 
with sorbic acid at 6.25 mM and thymol at 0.68 mM; SC1= infected basal diet with sorbic acid at 25 mM 
and carvacrol at 2.72 mM; SC2= infected basal diet with sorbic acid at 12.50 mM and carvacrol at 1.36 
mM; SC3= infected basal diet with sorbic acid at 6.25 mM and carvacrol at 0.68 mM. 
 
Treatment 4h n 8h n pH n 
CTR 8.68 ± 0.93 a 5 9.72 ± 1.70 ab 5 6.88 ± 0.15 b 5 
S 11.23 ± 0.48 ab 5 8.06 ± 1.66 a 5 6.79 ± 0.04 b 5 
ST1 11.74 ± 2.95 ab 5 13.83 ± 0.97 c 5 6.59 ± 0.04 a 5 
ST2 8.52 ± 2.93 a 5 11.03 ± 1.18 ab 5 6.59 ± 0.10 a 5 
ST3 10.29 ± 1.05 ab 5 9.69 ± 0.78 b 5 6.75 ± 0.13 b 5 
SC1 12.77 ± 0.78 b 5 12.52 ± 1.43 c 5 6.83 ± 0.03 b 5 
SC2 8.05 ± 2.98 a 5 10.14 ± 2.07 ab 4 6.88 ± 0.07 b 5 
SC3 11.28 ± 1.77 ab 5 10.55 ± 1.12 ab 5 6.85 ± 0.02 b 5 
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Table 4.6. Second trial. Counts of Salmonella Typhimurium (log10 CFU mL-1) at 4, 8 and 24h of an in 
vitro incubation of swine intestinal inoculum.  Values are indicated as means ± SD. Different letters within 
the same column are significantly different (P<0.05). N.D.= under the detection limit. CTR= basal diet; S= 
basal diet infected with Salmonella Typhimurium (106 CFU/mL); ST1= infected basal diet with sorbic acid 
at 25 mM and thymol at 2.72 mM; ST2= infected basal diet with sorbic acid at 12.50 mM and thymol at 
1.36 mM; ST3= infected basal diet with sorbic acid at 6.25 mM and thymol at 0.68 mM; SC1= infected 
basal diet with sorbic acid at 25 mM and carvacrol at 2.72 mM; SC2= infected basal diet with sorbic acid 
at 12.50 mM and carvacrol at 1.36 mM; SC3= infected basal diet with sorbic acid at 6.25 mM and 
carvacrol at 0.68 mM.  
 
Treatment 4h n 8h n 24h n 
CTR 4.52 ± 0.82 4 4.19 ± 0.58 3 3.67 ± 0.21 2 
S 5.20 ± 0.76 5 4.49 ± 0.59 5 3.57 ± 0.79 2 
ST1 4.61 ± 0.81 5 4.82 ± 0.86 5 3.61 ± 0.63 5 
ST2 4.59 ± 0.30 5 4.99 ± 0.50 5 3.73 ± 0.61 4 
ST3 5.33 ± 0.50 5 4.95 ± 0.44 5 3.41 ± 0.24 3 
SC1 N. D. 5 N. D. 5 N. D. 5 
SC2 5.43 ± 0.60 5 4.93 ± 0.46 5 3.32 ± 0.71 2 
SC3 5.19 ± 0.25 5 4.92 ± 0.31 3 3.98 ± 0.34 5 
 
 
 
 
4.4. Discussion 
Comparison between in vitro fermentation with two organic acids showed that sorbic 
acid inhibited fermentation activity, as indicated by maximum gas production, and 
Salmonella growth at the highest concentration tested. 
Carvacrol and thymol have the same chemical structure. The only difference is OH- 
position on the phenolic ring, and probably for this reason this compounds showed 
different antimicrobial activity. 
In particular, carvacrol in combination with an organic acid is more active against 
Salmonella compared to thymol. 
Syringes showed the ability of citric acid at different concentrations to stimulate 
fermentation activity of cecal microflora, resulting in a significant increase in the gas 
production in all treatments in which this acid was present. 
In caecum, citric acid represented a substrate for microflora. It is known that several 
bacterial strains can use citric acid as an energy source. 
Modulate the activity of microflora can improve available energy and nutrients, and 
reduce production of toxic substances. 
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Sorbic acid was more effective to contain the gas production and, combined with 
carvacrol, has allowed a general slowdown in fermentation. 
Antibacterial activity of substances against Salmonella Typhimurium was analyzed within 
vessels: carvacrol was more active in combination with citric acid than with sorbic acid. 
Combination of citric acid 31.25 mM and carvacrol 1.36 mM showed a reduction of 
Salmonella growth of 46%. 
Total inhibition of Salmonella growth was achieved in treatments with 25 mM sorbic 
acid plus 2.72 mM carvacrol. 
These results, particularly the second one, suggest that the use of carvacrol in 
combination with an OA could represent an effective approach to contain Salmonella 
gastrointestinal infections in pigs. 
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5. ANTICLOSTRIDIAL MICROENCAPSULATED BLEND OF 
ORGANIC ACIDS AND NATURAL IDENTICAL FLAVOURS IN A 
BROILERS CHALLENGE STUDY 
 
5.1. Aim of the study 
The aim of this study was to investigate the efficacy of a microencapsulated blend of 
organic acid and natural identical flavours as a tool to contain negative effects, in terms 
of health and loss of performance, associated to Clostridium proliferation in the 
intestine of broilers in the absence of antibiotic growth promoters. 
 
5.2. Materials and method 
Bacterial cultures and growth conditions 
Throughout the study, C. perfringens type A (ATCC 13124) was revitalized and 
subcultured in reinforced clostridial broth (Oxoid Ltd.) in anaerobic conditions at 37°C 
for 24 h. 
 
Table 5.1. Basal diet composition and chemical analysis (% as fed basis). 
 
Floor pen study 
 
I phase (0-14 d) II phase (15-42 d) 
Ingredients   
Soft wheat meal 39.0 40.0 
Soybean meal 40.0 35.0 
Corn meal 13.9 16.5 
Soybean Oil 3.2 5.0 
Dicalcium phosphate 1.9 1.9 
Calcium carbonate 0.6 0.5 
Vitamins and minerals1 0.5 0.5 
Salt (NaCl) 0.2 0.2 
Lysine HCL 0.16 - 
Methionine DL 0.3 0.2 
Sodium bicarbonate 0.15 0.15 
Analyzed Nutrients   
Dry matter 87.91 89.55 
Crude protein 25.08 21.71 
Ether extract 5.30 6.75 
Crude fibre 2.85 2.65 
Ash 5.99 5.76 
Metabolizable Energy 
Kcal/kg 2838 2920 
1 providing per kg: vit. A: 2.500.000 UI; cholecalciferol: 15 mg; vit. E: 15.000 UI; vit. K: 1.200 mg; vit. B1 : 
400 mg ; vit. B2 : 1.600 mg ; Pantothenic acid: 2.500 mg; vit. B6: 1.200 mg; Biotin: 30 mg; Folic acid: 250 
mg; vit. C: 20.000 mg; vit. PP : 8.000 mg ; vit. B12 : 6 mg ; Cu : 1.000 mg ; Fe : 10.000 mg ; Mn : 30.000 
mg ; Se : 40 mg ; Zn : 15.000 mg ; I : 200 mg ; Co : 40 mg. 
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Animals and Diets.  
Two-hundred and sixteen male broilers Ross 508 1-day-old (34.7 ± 2.2 g) were 
randomly allocated in 18 pens divided in 3 experimental groups (d0): a negative control 
group (CTR) fed the basal diet (tab. 5.1); a group inoculated with C. perfringens (CP); a 
group (AVI) inoculated with C. perfringens, and fed a diet supplemented with 300 ppm 
of a microencapsulated blend of organic acid and nature-identical compounds (EP 
1391155B1; Vetagro S.p.A., Italy). 
All diets were formulated as isoproteic and isoenergetic, without antibiotic growth 
promoters and coccidiostatic drugs. Birds were fed ad libitum for 42 days. On day 0, 14, 
and 42 since the beginning of the study, BW and ADFI  were recorded. ADG and FCR 
during the periods 0-14, 15-42 and 0-42 days, were calculated.  
The study was conducted in the research facilities of CERZOO (Piacenza, Italy), which 
is Good Laboratory Practices-certified. The ethical committee of the University of 
Bologna reviewed and approved the experimental protocol. 
Evaluation of Growth Performance. 
On d 0, 14, and 42 since the beginning of the study, BW and ADFI were recorded. 
Average daily gain and FCR during the periods of 0 to 14, 15 to 42, and 0 to 42 d were 
calculated. 
Fecal and Intestinal Sampling. 
Excreta from 5 birds/pen were sampled on d 11, 12, and 13, and on each day, the 5 
birds/pen samples were pooled to have 1 sample per pen. Samples were then plated on 
to violet red bile, Rogosa, and tryptose-sulfite-cycloserine agar for the enumeration of 
coliforms, LAB, and C. perfringens, respectively. On d 14, twelve birds per treatment (2 
birds/pen) were killed and analyzed for intestinal lesions and C. perfringens colonic 
counts. On d 42, twenty-four birds per treatment (4 birds/pen) were slaughtered, and 
ileum and cecum were sampled for the enumeration of coliforms, LAB, and C. 
perfringens as described previously. 
Statistical Analysis. 
The pen was the experimental unit for growth performance and fecal counts, whereas 
each animal was the experimental unit for intestinal counts. Data were analyzed with 
one-way ANOVA, followed by Fisher post-test to compare the means of groups (SAS 
Software, release 2002-2003, SAS Institute, Milan, Italy). Differences were stated as 
significant at P≤0.05. 
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5.3. Results  
Health Status of Animals, Intestinal Lesions, and Bacterial Counts. 
Mortality was 4.2% and 6.9% for CP and AVI groups, respectively, whereas it was null 
for the CTR unchallenged animals. Although in dead animals there were no clinical 
signs and typical lesions of NE, it could be presumed that the bacterial challenge may 
have had a negative influence on broiler health status. The necroscopic examination of 
animals slaughtered at 14d and 42d did not show typical lesions of NE. No statistical 
differences were found among treatments for coliforms, LAB and C. perfringens in 
excreta, colon, and ileum counts. Statistical differences were found among feeding 
treatments for lactic acid bacteria counts in caecum content at 42d: the values are lower 
in CP group vs. CTR and AVI groups (-4.56% and -4.65%, respectively; P=0.0455). 
 
Table 5.2. BW, average daily gain (ADG), average daily feed intake (ADFI), and feed conversion rate 
(FCR) of broilers. 
 
 Treatment1  Statistics2 
Item CTR CP AVI  SE P-value 
Initial BW, g 34.7 35.2 34.7  0.22 0.19 
I phase (0-14d)       
ADFI, g  39.4 37.5 38.8  2.36 0.84 
ADG, g  16.7 16.5 16.0  0.45 0.55 
FCR 2.38 2.30 2.43  0.19 0.90 
14 d BW, g 269 266 273  6.43 0.72 
II phase (15-42d)       
ADFI, g  139.4b 133.3ab 129.3a  2.56 0.04 
ADG, g  71.1 68.0 70.6  1.04 0.11 
FCR 1.96 1.96 1.83  0.05 0.11 
Final BW, g 2266 2244 2254  29.16 0.86 
Overall (0-42d)       
ADFI, g  101.9b 96.8ab 93.9a  2.00 0.04 
ADG, g  50.7 48.4 49.2  0.85 0.18 
FCR 2.01 2.01 1.91  0.05 0.30 
EPEF* 268.42 254.76 260.12  - - 
a,b
 Means with different superscript within the same row differ significantly (P<0.05). 
1
 CTR = negative control group; CP = C. perfringens challenged control group; AVI= C. perfringens challenged group fed 
diet supplemented with a microencapsulated blend of organic acids and nature-identical compounds (produced by Vetagro 
S.p.A., Italy). 
2 n = 6; SE= Standard error. 
*
  EPEF (European Production Efficency Factor)= [BW(kg) * Liveability(%)/Age at depletion (days) * F:G]*100 
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Growth performance. 
Data are shown in table 5.2. No statistical differences were found among treatments for 
ADFI, ADG, and FCR ratio. In the 2nd phase, ADFI was significantly lower for AVI vs 
CTR (-7.25%; P=0.04). During the same period, ADG was numerically lower in CP 
group vs. CTR and AVI groups (68.0g vs. 71.1g and 70.6g, respectively; P=0.11); FCR 
ratio was numerically lower in AVI group vs. CTR and CP groups (1.83 vs. 1.96 and 
1.96, respectively; P=0.11). Overall, ADFI was significantly lower for AVI group 
compared to CTR group (-7.85%; P=0.04), with no significant changes in overall ADG, 
FCR, and final BW, even if FCR was numerically lower for AVI group compared to 
CTR and CP (1.91 vs. 2.01, respectively). EPEF showed a value numerically higher for 
AVI compared to CP (260.12 vs. 254.76, respectively) 
 
5.4. Discussion  
Subacute enteritis is very frequent, with great economic implication associated to lower 
digestion and absorbtion, feed efficiency and impairment of growth performance 
(Kaldhusdal et al., 2001; Loveland and Kaldhusdal, 2001; Hofacre et al., 2003; Van 
Immerseel et al., 2004). 
This study aimed to induce subacute necrotic enteritis in broiler chickens, in order to 
understand if the supplementation of a microencapsulated blend of organic acid and 
nature-identical compounds could restore growth performance to regular levels.  
No effect was found in the number of viable C. perfringens cells in the intestines of 
slaughtered chickens, but the number of lactic acid bacteria in CTR and AVI was higher 
than CP (data not showed). This might be explained by considering the competitive 
effect of in vivo intestinal microbial content. Probably microbial competition can be 
restore by AVI, that could have other bacterial target and could stimulate proliferation 
of  lactic acid bacteria, instead to directly reduce C. perfringens proliferation.  
During the second phase, and in overall study, animals feeding AVI showed lower 
ADFI compared to CTR (7%). These results can be caused by challenge with C. 
perfringens, because CP group showed lower values compared to CTR (5%), even if 
these data were no statistically significant. 
ADFI differences had no effect on final body weight of birds, that showed no statistical 
difference among treatment. FCR among groups showed no statistical differences, even 
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if FCR was numerically lower for AVI (-5%) compared to CP and CTR. These results 
evidenced that the use of a microencapsulated blend of organic acids and flavours 
helped birds to restore weight to levels comparable to unchallenged animals. The blend 
used probably acts on intestinal microflora, stimulating positive bacteria such as lactic 
acid bacteria and increasing the competitiveness for the environment. Restore normal 
performance conditions results in decreasing of  economic lost for the farmer as 
indicated by higher EPEF of AVI group compared to CP (+2%) . 
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6. PEDIOCIN A IMPROVES GROWTH PERFORMANCE OF 
BROILERS CHALLENGED WITH CLOSTRIDIUM PERFRINGENS 
 
6.1. Aim of the study 
The aim of this study was to investigate the efficacy of the anticlostridial pediocin A 
from P. pentosaceus FBB61 (WO/2004/087189; Piva and Casadei, 2004) as a tool to 
contain negative effects, in terms of health and loss of performance, associated to 
Clostridium proliferation in the intestine of broilers in the absence of antibiotic growth 
promoters, through 2 subsequent investigations (Grilli et al., 2009). 
 
6.2. Materials and method 
Bacterial cultures and growth conditions 
Throughout the studies, P. pentosaceus FBB61 (ATCC 43200) and its isogenic mutant 
were revitalized and subcultured in M17 broth (Oxoid Ltd., Basingstoke, UK) 
supplemented with 1% (wt/vol) glucose at 34°C for 18 h, whereas C. perfringens type A 
(ATCC 13124) was revitalized and subcultured in reinforced clostridial broth (Oxoid 
Ltd.) in anaerobic conditions at 37°C for 24 h. 
Expression and purification of Pediocin A 
Semipurified pediocin A for antimicrobial assay was obtained as described previously 
by Casadei et al. (2009). For the in vivo studies, pediocin A preparation was obtained as 
follows. A P. pentosaceus FBB61 cultural broth was collected to define the sample titer 
of pediocin A and bacteria concentration. The so-obtained broth was used in the 
appropriate amount for the floor pen study, whereas for the pilot study, the cultural 
broth underwent a purification step through centrifugation at 16,500 × g at 4°C for 10 
min. Supernatant was collected and filtered with Stericup (Millipore Corporation, 
Bedford, MA) through a membrane with pores of 0.45-µm diameter and then titered for 
pediocin A. Titration of activity of pediocin A was performed through an agar spot test 
technique. Briefly, from each supernatant filtered produced, 20-µL aliquots were 
delivered into wells of a M17 agar plate previously seeded with 20 µL of P. pentosaceus 
FBB61-2 (Daeschel and Klaenhammer, 1985) fresh overnight culture and incubated at 
39°C overnight. The sample titer [activity units (AU)/mL] was defined as the reciprocal 
of the highest dilution showing definite inhibition of the indicator lawn. 
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Antimicrobial Assay 
An antimicrobial assay was conducted to assess the most effective dose of pediocin A  
against C. perfringens to be used in in vivo challenge studies. The minimal inhibitory 
concentration (MIC) of pediocin A against C. perfringens type A (ATCC13124) was 
determined using a broth dilution method. The test was performed in disposable tubes 
containing two-fold dilutions (320 to 0.6 activity units AU/ml) of semi purified pediocin 
A in a reinforced clostridial broth (Oxoid Ltd, Basingstoke, UK). An overnight culture 
of C. perfringens was prepared and adjusted so that the final concentration in each tube 
was approximately 104 CFU/ml. The tubes were incubated anaerobically at 37°C for 24 
and 48 h. Bacterial growth was indicated by the presence of turbidity in the tube and 
measured by optical density (OD) at 600 nm (UltroSpec 3000 Pharmacia Biotech, 
Biochrom, Ltd, Cambridge, UK). The MIC was determined as the first tube, in 
ascending order, were the OD was 0.00. To confirm MIC, 100 µl of broth from each 
tube after 48 h of incubation was plated onto RCM agar. After 24 h of incubation the 
growth of viable cells was observed. The MIC was the lowest concentration which 
resulted in significant decrease in OD values where >99.9% or more of the initial 
inoculum was killed (Cosentino et al., 1999).  
 
Pilot Study 
Birds and Diets. 
Thirty-six female broilers Ross 508 (44.8 ± 1.8 g) were obtained 1-day hatch, and 12 
chickens were placed in each of 3 150x60cm isolation units equipped with bedding 
straw, drinkers, heating lamps, and a filtered air supply. Each isolation unit was 
assigned to one of the 3 experimental groups: a negative control (CTR), fed basal diet 
(tab. 6.1); a positive control, fed the same diet added with supernatant filtrate of a 
cultural broth of the isogenic mutant P. pentosaceus FBB61-2 devoid of pediocin A 
expression (Bac-); a treated group (Bac+), fed the control diet supplemented with 
supernatant filtrate of a cultural broth of P. pentosaceus FBB61 (Bac+). In Bac+ group, 
pediocin A was provided at 80 AU/g of feed. All birds were challenged with C. 
perfringens. 
Birds were fed ad libitum for 21 days. On day 0, 9, 14, and 21 from the beginning of the 
study, BW and average daily feed intake (ADFI) were recorded. Average daily gain 
(ADG), and feed conversion rate (FCR) during the periods 0-9, 0-14, 15-21, 0-21 days, 
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were calculated. The study was conducted in the facilities of the University of Bologna, 
whose ethical committee reviewed and approved the experimental protocol. 
Microbial challenge 
On day 9, animals were challenged by intracrop administration of vaccinal oocysts at a 
dose 50 times higher than the recommended one to produce a mild  intestinal 
coccidiosis, and favour C. perfringens infection (Shane et al., 1985). 
A fresh overnight culture of C. perfringens type A was administered per os on day 14, 
15 and 16, twice daily (106 CFU/bird).  
Evaluation of Growth Performance. 
 On d 0, 9, 14, and 21 from the beginning of the study, BW and ADFI were recorded. 
Average daily gain and feed conversion rate (FCR) during the periods of 0 to 9, 0 to 14, 
15 to 21, and 0 to 21 d were calculated.  
Fecal and Intestinal Sampling. 
One pool of feces was collected from each isolator at 11, 12, 13, and 14 d, to perform 
oocyst counts with an optical microscope. At 21 d, 5 birds per group were killed, 
analyzed for intestinal lesions, and ileal contents were sampled and plated on to violet 
red bile, Rogosa, and tryptosesulfite- cycloserine agar (Oxoid Ltd.) for enumeration of 
coliforms, lactic acid bacteria (LAB), and C. perfringens, respectively. 
Statistical Analysis. 
The isolator was the experimental unit for ADFI and FCR calculations, and for oocysts 
shedding. These data did not undergo statistical analysis, whereas each animal was the 
experimental unit for BW, ADG calculations, and microbiological counts, and were 
analyzed by 1-way ANOVA followed by Tuckey post-test (Graphpad Software 4.1, San 
Diego, CA). Differences were stated as significant at P < 0.05. 
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Table 6.1: Basal diet composition and chemical analysis (% as fed basis). 
 
Floor pen study 
 Pilot study 
I phase (0-14 d) II phase (15-42 d) 
Ingredients    
Soft wheat meal 35.0 39.0 40.0 
Soybean meal 30.0 40.0 35.0 
Corn meal 27.2 13.9 16.5 
Soybean Oil 3.0 3.2 5.0 
Dicalcium phosphate 2.0 1.9 1.9 
Calcium carbonate 1.3 0.6 0.5 
Vitamins and minerals1 0.5 0.5 0.5 
Salt (NaCl) 0.3 0.2 0.2 
Lysine HCL 0.3 0.16 - 
Methionine DL 0.3 0.3 0.2 
Sodium bicarbonate 0.1 0.15 0.15 
Analyzed Nutrients    
Dry matter 88.69 87.91 89.55 
Crude protein 22.22 25.08 21.71 
Ether extract 5.43 5.30 6.75 
Crude fibre 3.08 2.85 2.65 
Ash 6.19 5.99 5.76 
Metabolizable Energy 
Kcal/kg 2990 2838 2920 
1 providing per kg: vit. A: 2.500.000 UI; cholecalciferol: 15 mg; vit. E: 15.000 UI; vit. K: 1.200 mg; vit. B1 : 400 mg ; 
vit. B2 : 1.600 mg ; Pantothenic acid: 2.500 mg; vit. B6: 1.200 mg; Biotin: 30 mg; Folic acid: 250 mg; vit. C: 20.000 mg; 
vit. PP : 8.000 mg ; vit. B12 : 6 mg ; Cu : 1.000 mg ; Fe : 10.000 mg ; Mn : 30.000 mg ; Se : 40 mg ; Zn : 15.000 mg ; I : 
200 mg ; Co : 40 mg. 
 
 
 
Floor Pen Study 
Animals and Diets.  
Two-hundred and sixteen male broilers Ross 508 1-day-old (34.7 ± 2.2 g) were 
randomly allocated in 18 pens divided in 3 experimental groups (d0): a negative control 
group (CTR) fed the basal diet (tab. 6.1); a group inoculated with C. perfringens (CP); a 
group (PA) inoculated with C. perfringens, and fed a diet supplemented with P. 
pentosaceus FBB61 (107 CFU/g),  and pediocin A, providing 60 and 40 AU/g fed in the 
1st and 2nd phase diets (0-14d; 15-42d), respectively. All diets were formulated as 
isoproteic and isoenergetic, without antibiotic growth promoters and coccidiostatic 
drugs. Birds were fed ad libitum for 42 days. On day 0, 14, and 42 since the beginning 
of the study, BW and ADFI  were recorded. ADG and FCR during the periods 0-14, 15-
42 and 0-42 days, were calculated.  
The study was conducted in the research facilities of CERZOO, which is Good 
Laboratory Practices-certified. The ethical committee of the University of Bologna 
reviewed and approved the experimental protocol. 
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Evaluation of Growth Performance. 
On d 0, 14, and 42 since the beginning of the study, BW and ADFI were recorded. 
Average daily gain and FCR during the periods of 0 to 14, 15 to 42, and 0 to 42 d were 
calculated. 
Fecal and Intestinal Sampling. 
Excreta from 5 birds/pen were sampled on d 11, 12, and 13, and on each day, the 5 
birds/pen samples were pooled to have 1 sample per pen. Samples were then plated on 
to violet red bile, Rogosa, and tryptose-sulfite-cycloserine agar for the enumeration of 
coliforms, LAB, and C. perfringens, respectively. On d 14, twelve birds per treatment (2 
birds/pen) were killed and analyzed for intestinal lesions and C. perfringens colonic 
counts. On d 42, twenty-four birds per treatment (4 birds/pen) were slaughtered, and 
ileum and cecum were sampled for the enumeration of coliforms, LAB, and C. 
perfringens as described previously. 
Statistical Analysis.  
The pen was the experimental unit for growth performance and fecal counts, whereas 
each animal was the experimental unit for intestinal counts. Data were analyzed with 1-
way ANOVA, followed by Fisher post-test to compare the means of groups (SAS 
Software, release 2002-2003, SAS Institute, Milan, Italy). Differences were stated as 
significant at P≤0.05. 
 
6.3. Results  
The MIC of pediocin A against 104 CFU/ml of C. perfringens was 20 AU/ml and 40 
AU/ml after 24 and 48 h of incubation, respectively. 
 
Pilot Study 
The MIC of pediocin A against 104 CFU/ml of C. perfringens was 20 AU/ml and 40 
AU/ml after 24 and 48 h of incubation, respectively. 
Health Status of Animals, Intestinal Lesions, Oocyst Shedding, and Bacterial Counts. 
Only one animal died in the CTR group, but the cause of death was not associated to 
NE, but with colibacillosis. Macroscopic evaluation of intestinal mucosa showed specks 
of blood with focal distribution throughout the intestine, as well as hemorrhage areas. 
Generally, there was a lack of marked differences between the Bac+ and Bac- groups. 
No brownish or diphteric pseudo-membranes were observed. Gram stained smears of 
intestinal mucosa demonstrated rod-shaped bacteria with typical C. perfringens 
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morphology. Oocyst shedding was less pronounced for Bac+ and Bac- groups than for 
CTR throughout the collection days. There were no statistical differences among 
treatments for coliforms, LAB and  C. perfringens in ileal samples. 
Growth Performance. 
Data are showed in table 2. During the 1st period (0-9d), ADG was significantly higher 
for Bac+ vs. CTR and Bac- (+31% and +21% vs. CTR and Bac-, respectively; P < 
0.01), and consequently, BW was higher for Bac+ vs. CTR and Bac- (+24% and +17% 
vs. CTR and Bac-, respectively; P < 0.01). On d14, ADG was still higher for Bac+ 
compared to CTR (+23%, P = 0.02), and BW was higher for Bac+ and Bac- compared 
to CTR (+23% and +14% respectively; P = 0.02). No statistical differences were found 
among treatments for growth performance on d21. EPEF value was numerically higher 
for Bac+ compared to CTR (+3%). 
 
Table 6.2: BW, average daily gain (ADG), average daily feed intake (ADFI), and feed conversion rate 
(FCR) of broilers in the pilot study 
 
 Treatment1  Statistics2 
Item CTR Bac- Bac+  SEM P-value 
Initial BW, g 44.8 43.2 45.4  1.60 0.24 
0-9d       
ADFI, g 27.41 23.70 27.41  - - 
ADG, g 15.45b 16.79b 20.31a  1.85 <0.01 
FCR 1.34 1.10 1.08  - - 
9d BW, g 183.8b 194.3b 228.3a  14.24 <0.01 
0-14d       
ADFI, g 34.29 33.45 33.69  - - 
ADG, g d 21.20b 24.20ab 26.07a  2.28 0.02 
FCR 1.62 1.38 1.29  - - 
14d BW, g 296.8b 338.8a 365.0a  27.29 0.02 
15-21d       
ADFI, g 73.11 70.24 69.23  - - 
ADG, g 44.24 40.55 39.77  8.58 0.75 
21d BW, g 606.5 622.7 642.9  44.89 0.59 
Overall 0-21d       
ADFI, g 42.43 42.74 44.03  - - 
ADG, g 26.75 27.59 28.47  2.86 0.71 
FCR 1.60 1.44 1.44  - - 
EPEF* 180.5 205.9 212.7  - - 
a,bMeans with different superscript within the same row differ significantly (P < 0.05). 
1CTR =  basal diet; Bac- = basal diet with supernatant filtrate of the isogenic mutant of P. pentosaceus FBB61-2 non 
producing pediocin A; Bac+ = basal diet with supernatant filtrate of P. pentosaceus FBB61 producing pediocin A. 
2For BW and ADG, n = 12; for FI and FCR, n = 1. 
*
  EPEF (European Production Efficency Factor)= [BW(kg) * Liveability(%)/Age at depletion (days) * F:G]*100 
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Floor Pen Study 
Health Status of Animals, Intestinal Lesions, and Bacterial Counts. 
Mortality was 4.2% and 6.9% for CP and PA groups, respectively, whereas it was null 
for the CTR unchallenged animals. Although in dead animals there were no clinical 
signs and typical lesions of NE, it could be presumed that the bacterial challenge may 
have had a negative influence on broiler health status. The necroscopic examination of 
animals slaughtered at 14d and 42d did not show typical lesions of NE. No statistical 
differences were found among treatments for coliforms, LAB and C. perfringens in 
excreta, colon, ileum, and caecum counts. 
Growth performance. 
Data are shown in table 3. No statistical differences were found among treatments for 
ADFI  between 0-14d. During the same period, ADG was significantly higher for PA vs 
CTR and CP (+14% and +15%, respectively; P = 0.01), and FCR ratio tended to be 
numerically lower in PA vs CTR and CP (-23% and -20%, respectively; P = 0.08). At 
14d, BW was significantly higher for PA vs CTR and CP (+17% and +18%, 
respectively; P < 0.01). In the 2nd phase, ADG of PA tended to be higher compared to 
CP group (+4%, P = 0.08), and equal to the unchallenged birds. Overall, AFI was 
significantly lower in the PA group compared with the CTR group, with no significant 
changes in overall ADG, FCR, and final BW. EPEF value was numerically higher for 
PA compared to CTR (+8%). 
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Table 6.3. BW, average daily gain (ADG), average daily feed intake (ADFI), and feed conversion rate 
(FCR) of broilers in the floor pen study 
 
 Treatment1  Statistics2 
Item CTR CP PA  SEM P-value 
Initial BW, g 34.7 35.2 34.7  0.18 0.12 
I phase (0-14d)       
ADFI, g  39.4 37.5 34.5  2.16 0.31 
ADG, g  16.7b 16.5b 19.0a  0.59 0.01 
FCR 2.38 2.30 1.83  0.17 0.08 
14 d BW, g 269b 266b 315a  7.63 <0.01 
II phase (15-42d)       
ADFI, g  139.4 133.3 130.5  3.39 0.20 
ADG, g  71.1 68.0 70.7  0.97 0.08 
FCR 1.96 1.96 1.85  0.06 0.34 
Final BW, g 2266 2244 2296  27.11 0.41 
Overall (0-42d)       
ADFI, g  101.9a 96.8ab 93.1b  2.32 0.05 
ADG, g  50.7 48.4 50.6  0.93 0.17 
FCR 2.01 2.01 1.85  0.07 0.19 
EPEF* 268.4 254.8 275.0  - - 
a,b
 Means with different superscript within the same row differ significantly (P < 0.05). 
1
 CTR = negative control group; CP = C. perfringens challenged control group; PA= C. perfringens challenged group fed 
diet supplemented with P. pentosaceus and pediocin A 
2 n = 6. 
*
  EPEF (European Production Efficency Factor)= [BW(kg) * Liveability(%)/Age at depletion (days) * F:G]*100 
 
 
 
6.4. Discussion 
After the ban of antibiotic growth promoters, as of January 1st 2006, clostridial enteritis 
is a urgent issue in livestock production, primarely because of the loss of performance 
of affected animals. Clostridium  perfringens is the main causative agent of NE, a 
worldwide spread multi-factorial disease that can affect birds both in acute and sub-
clinical forms. Acute NE may cause 1% of daily mortality up to a 30% of mortality in 
the entire production cycle (Van Immersel et al., 2004; Dahiya et al., 2006). Subacute 
enteritis is very frequent, with great economic implication associated to lower digestion 
and absorbtion, feed efficiency and impairment of  growth performance ( Kaldhusdal et 
___________________________________________________________In vivo studies 
 80 
al., 2001; Loveland and Kaldhusdal , 2001; Hofacre et al. , 2003; Van Immerseel et al., 
2004). 
This study aimed to induce subacute necrotic enteritis in broiler chickens, in order to 
understand if the supplementation of pediocin A and its producer strain P.  pentosaceus 
FBB61, could restore growth performance to regular levels.  
In the pilot study, broilers challenged with C. perfringens showed lesions typical of NE, 
whereas, in the floor pen study, broilers challenged with C. perfringens did not produce 
clinical signs of NE and there was no mortality directly associated to C. perfringens 
exposure. The same results were shown by other authors, who observed no clinical 
signs of NE after Clostridium challenge in broiler chickens (Olkowski et al, 2006; Drew 
et al, 2004). Even though the challenge model used did not produce acute NE, birds 
challenged with C. perfringens had low performance, if compared to those of Ross 
performance objectives, and developed a subacute enteritis characterized by low ADFI 
and ADG.  
Even though there is plenty of literature on NE challenge models and management, 
limited information is available about the addition of bacteriocins to bird diets, thus 
outlining the unicity of the present study. Lactic acid bacteria and their bacteriocins 
have been long studied as food preservatives and starters, as they improve food shelf-
life, and organoleptic and nutritional value (Wood and Holzapfel, 1995; Leroy and De 
Vuyst, 2004; De Vuyst and Leroy,  2007); the most popular example of LAB derived 
bacteriocin is nisin, which is recognized as a GRAS ingredient by the FDA since 1988. 
By definition, bacteriocins are tipically active against closely related bacteria limiting 
their use to a selected number of pathogenic strains; pediocin A was in fact described to 
have a broad spectrum of activity  against numerous strain of gram-positive bacteria and 
foodborne pathogens among which L. monocytogenes (Piva and Headon 1994). In the 
present study we found that pediocin A had strong inhibitory capacities against C. 
perfringens type A in an in vitro antimicrobial assay. Being C. perfringens the organism 
involved in the pathogenesis of poultry enteritis, pediocin A application in feeds seems 
to be innovative. Few data are available about the use of bacteriocins in feeding poultry 
as a method to counteract intestinal pathogens development and shedding, even though 
in recent times there is growing interest in such a field. Cole et al. (2006) described the 
efficacy of bacteriocins derived from a strain of L. salivarius against C. coli 
colonization in turkeys, as well as Stern et al. (2005), but no studies with C. perfringens 
are currently available. 
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In these experiments, we studied the effect of feeding a partially purified bacteriocin, 
pediocin A, and its P. pentosaceus producer strain to animals challenged with high 
doses of C. perfringens (106 to 108 CFU). The minimal inhibitory concentration of 
pediocin A against C. perfringens was 40 AU/ml after 48 h, and, although equal versus 
to higher doses were used in the in vivo experiments (80 AU/g of feed in the pilot study, 
and 40 to 60 AU/g feed in the floor pen study) no effect was found in the number of 
viable C. perfringens cells in the intestines of slaughtered chickens. This might be 
explained by considering the diluting effect of in vivo intestinal microbial content. It is 
well known that the intestine of  birds hosts a very large bacterial population (104-105 
CFU/g and 1010-1011 CFU/g in small and large intestine, respectively;) among which a 
large portion is made of gram-positive (Bjerrum et al., 2006). Being gram-positive 
organisms the target of pediocin A, it is possible that there was a sparing effect on C. 
perfringens due to the high competitiveness of the environment. Nevertheless, animals 
fed with pediocin A and P. pentosaceus had better performance in both experiments. In 
the pilot study, during the first period (0-9 d, before challenge) and at 14d (after 
challenge), birds fed with pediocin A had higher ADG by a 20% and 19%, respectively, 
when compared to untreated animals. The results of the first experiment were confirmed 
in the floor pens study, where a larger number of replicates and animals was used. In 
facts, birds fed with pediocin A-containing diet had higher ADG by 14% and 15% when 
compared to a negative and a positive control, respectively, during the period 0-14d 
immediately  after challenge (P = 0.01). During the second phase (15-42d), after the 
bacterial challenge, the difference in ADG between infected animals with or without 
pediocin treatment was less pronounced (4%) without reaching significant levels (P = 
0.08).  
These results can be explained by the fact that, even if we were not able to measure 
appreciable reduction of C. perfringens counts, pediocin A might have targeted other 
gram-positive species, thus revealing a possibility for pediocin A to beneficially 
modulate bacterial balance, by favouring beneficial bacteria at the site where noxious 
bacterial overgrowth occurs during enteritis (Casadei et al., 2009). Previous data 
showed that pediocin A was able in vitro to reduce the extent of fermentation, resulting 
in a long-lasting utilization of fermentable energy sources, and to control intestinal 
microbial metabolism (Casadei et al., 2009). Even though antibiotic growth promoters 
mechanism of action is not still fully understood, its known effects in depressing 
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microflora growth, thereby increasing growth performance by 5 to 10 %, make pediocin 
A result in a growth promoting analogue. 
Even though C. perfringens is the main causative agent of NE, there are many factors 
that can contribute to the pathology to develop, and C. perfringens itself is not enough 
to predispose to NE to rise, even when administered at 108 CFU/d. It is likewise evident 
that such an high number of C. perfringens cells in the intestine may disturb microflora 
metabolism, alter the intestinal fermentation pattern, and impair digestion and 
absorbtion. In both experiments, pediocin A helped birds to restore weight to levels 
comparable to unchallenged animals. Moreover, in the second experiment, along with 
pediocin A, we added P. pentosaceus producer strain to the diet, that could have had 
exerted probiotic effects, growing in the intestine of birds, and then activating in situ 
pediocin A production. This observation is supported by previous study results, where 
P. pentosaceus FBB61 producer strain added to an in vitro cecal fermentation system 
significantly modified the extent of fermentation by reducing ammonia concentration 
and isoacids molar proportions (Piva et al., 1995). Recently, Lee et al. (2007) 
demonstrated the growth promoting and protecting effect of a Pediococcus-based 
probiotic in Eimeria challenged birds, reporting higher ADG and a decrease in fecal 
oocysts shedding in birds fed with probiotic when compared to challenged birds without 
probiotic supplementation. Mountzouris et al. (2007) found that feeding broiler 
chickens with a multibacterial species probiotic, containing  Pediococcus strain, 
significantly improved growth performance and, to an extent, cecal microflora 
composition, when compared to avilamycin.  
In conclusion, our data demonstrated that both pediocin A alone, and the combination 
with its producer strain P. pentosaceus, have in vivo growth promoting effects, further 
substantiating previous in vitro results (Casadei et al., 2009), and that pediocin A 
allowed to restore optimal growth in birds challenged with the enteropathogenic C. 
perfringens (Grilli et al., 2009).  
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7. CONCLUSIONS 
 
In the contest of improving food safety, as required by the European Authority and 
consumer, the attention was focused on microbiological risk in food animal. Clostridium 
perfringens and Salmonella spp. were the major causes of human infection. In particular, 
to prevent microbiological risk is necessary decrease slaughterhouse cross-contamination. 
Aim of this study was to investigate the antimicrobial effect of natural compounds, such 
as, organic acids, nature-identical compounds, and bacteriocin, against the main 
foodborne pathogens Clostridium perfringens and S. Typhimurium. 
The first step was to study the antimicrobial in vitro activity of several organic acids and 
flavours against C. perfringens and Salmonella, in order to find possible synergisms 
among those compounds. The second step was to study their possible use in animal 
production to screen the role of such substances in controlling Salmonella infection in 
pigs in an in vitro system simulating the intestinal environment and microflora; and 
finally, substances under investigation were tested in vivo to evaluate their properties as 
feed additive to prevent clostridial infection in broilers. In parallel, a bacteriocin and its 
producer strain P. pentosaceus were tested in vivo to investigate their role into control C. 
perfringens infection in broilers. 
The Minimal Inhibitory Concentration results showed that organic acids in association 
with nature-identical compounds had a stronger antimicrobial activity compared to the 
same substance alone. In particular, carvacrol showed a strong antimicrobial activity 
when used in combination with an organic acid, both against C. perfringens and 
Salmonella. Carvacrol antimicrobial activity against gram-positive and gram-negative 
was confirmed by several authors (Dorman and Deans, 2000; Lambert et al., 2001; 
Peñalver et al., 2005). Organic acids alone were less effective than nature-identical 
compounds. 
The fermentation study clearly confirmed that carvacrol had a better activity when 
compared with thymol to control Salmonella infection in swine intestine. In particular 
the use of carvacrol with an organic acid could represent an effective approach to 
contain Salmonella gastrointestinal infections in pigs.  
The results obtained in vivo using a microencapsulated blend of organic acids and 
flavours to control C. perfringens infection evidenced that the blend helped birds to 
restore weight to levels comparable to unchallenged animals. The microencapsulated 
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blend probably acts on intestinal microflora, stimulating positive bacteria such as LAB 
and increasing the competitiveness for the environment. Restore normal performance 
conditions results in decreasing of economic lost for the farmer. 
The parallel in vivo study to analyse the effect of pediocin A and P. pentosaceus to 
control clostridial infection, demonstrated that both pediocin A alone, and mostly the 
combination with its producer strain P. pentosaceus, have in vivo growth promoting 
effects, further substantiating previous in vitro results (Casadei et al., 2009), and that 
pediocin A allowed to restore optimal growth in birds challenged with the 
enteropathogenic C. perfringens (Grilli et al., 2009) 
The use of a blend of carvacrol and an organic acid can be an useful instrument in 
controlling Salmonella infection, such as the use of a blend of organic acids and 
flavours or pediocin A and its producer strain contained clostridial infection. Reduction 
of foodborne pathogens shedding on farm and consequently at slaughter could improve 
meat safety for human consumption. 
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